US20070016233A1 - Vasoocclusive device for treatment of aneurysms - Google Patents

Vasoocclusive device for treatment of aneurysms Download PDF

Info

Publication number
US20070016233A1
US20070016233A1 US11/435,373 US43537306A US2007016233A1 US 20070016233 A1 US20070016233 A1 US 20070016233A1 US 43537306 A US43537306 A US 43537306A US 2007016233 A1 US2007016233 A1 US 2007016233A1
Authority
US
United States
Prior art keywords
cable
strands
coil
micro
radiopaque
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/435,373
Inventor
David Ferrera
Daniel Kurz
Lok Lei
Julia Larsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Spine LLC
Codman and Shurtleff Inc
DePuy Synthes Products Inc
Original Assignee
Ferrera David A
Kurz Daniel R
Lei Lok A
Larsen Julia A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrera David A, Kurz Daniel R, Lei Lok A, Larsen Julia A filed Critical Ferrera David A
Priority to US11/435,373 priority Critical patent/US20070016233A1/en
Publication of US20070016233A1 publication Critical patent/US20070016233A1/en
Assigned to CODMAN & SHURTLEFF, INC. reassignment CODMAN & SHURTLEFF, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MICRUS ENOVASCULAR LLC
Assigned to DEPUY SPINE, LLC reassignment DEPUY SPINE, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CODMAN & SHURTLEFF, INC.
Assigned to HAND INNOVATIONS LLC reassignment HAND INNOVATIONS LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DEPUY SPINE, LLC
Assigned to DePuy Synthes Products, LLC reassignment DePuy Synthes Products, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: HAND INNOVATIONS LLC
Assigned to CODMAN & SHURTLEFF, INC. reassignment CODMAN & SHURTLEFF, INC. CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVE SERIAL NUMBER 12/554,588 PREVIOUSLY RECORDED ON REEL 030352 FRAME 0973. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Assignors: MICRUS ENDOVASCULAR LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12145Coils or wires having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/1215Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12154Coils or wires having stretch limiting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12163Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a string of elements connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526Methods of manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00884Material properties enhancing wound closure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00893Material properties pharmaceutically effective
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12068Details concerning the detachment of the occluding device from the introduction device detachable by heat
    • A61B2017/12072Details concerning the detachment of the occluding device from the introduction device detachable by heat the heat created by laser light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09Guide wires
    • A61M2025/09191Guide wires made of twisted wires

Definitions

  • This invention relates generally to implantable devices for interventional therapeutic treatment or vascular surgery, and concerns a stranded micro-cable with enhanced radiopacity that can be used to fabricate a vascular device, a stent, a guidewire or the like. More particularly, the invention relates to three dimensional microcoil vasoocclusive devices fabricated from stranded micro-cable.
  • One specific field of interventional therapy that has been able to advantageously use recent developments in technology is the treatment of neurovascular defects. More specifically, as smaller and more capable structures and materials have been developed, treatment of vascular defects in the human brain which were previously untreatable or represented unacceptable risks via conventional surgery have become amenable to treatment.
  • One type of non-surgical therapy that has become advantageous for the treatment of defects in the neurovasculature has been the placement by way of a catheter of vasoocclusive devices in a damaged portion of a vein or artery.
  • Vasoocclusion devices are therapeutic devices that are placed within the vasculature of the human body, typically via a catheter, either to block the flow of blood through a vessel making up that portion of the vasculature through the formation of an embolus or to form such an embolus within an aneurysm stemming from the vessel.
  • the vasoocclusive devices can take a variety of configurations, and are generally formed of one or more elements that are larger in the deployed configuration than when they are within the delivery catheter prior to placement.
  • One widely used vasoocclusive device is a helical wire coil having a deployed configuration which may be dimensioned to engage the walls of the vessels.
  • vasoocclusive device that forms itself into a shape of an anatomical cavity such as an aneurysm and is made of a pre-formed strand of flexible material that can be a nickel-titanium alloy is known from U.S. Pat. No. 5,645,558, which is specifically incorporated by reference herein.
  • That vasoocclusive device comprises one or more vasoocclusive members wound to form a generally spherical or ovoid shape in a relaxed state.
  • the vasoocclusive members can be a helically wound coil or a co-woven braid formed of a biocompatible material, and the device is sized and shaped to fit within a vascular cavity or vesicle, such as for treatment of an aneurysm or fistula.
  • the vasoocclusive member can be first helically wound or braided in a generally linear fashion, and is then wound around an appropriately shaped mandrel or form, and heat treated to retain the shape after removal from the heating form.
  • Radiopacity can be provided in the vasoocclusive members by weaving in synthetic or natural fibers filled with powdered radiopaque material, such as powdered tantalum, powdered tungsten, powdered bismuth oxide or powdered barium sulfate, which can potentially be released during vascular surgery.
  • powdered radiopaque material such as powdered tantalum, powdered tungsten, powdered bismuth oxide or powdered barium sulfate, which can potentially be released during vascular surgery.
  • Another occlusion device for closing defects in vascular walls is known that is formed by a pair of distinct sections of varying configuration, which may be parabolic or conical bodies oriented to flare outward.
  • Yet another implantable vasoocclusive device is known that is formed by a complex, helically wound coil adapted to take on a secondary shape suitable for snugly fitting within a given vascular cavity upon deployment, that can be formed by winding the coil on a mandrel having radially extending poles.
  • vasoocclusive devices can be accomplished by a variety of means, including via a catheter in which the device is pushed through the catheter by a pusher to deploy the device.
  • the vasoocclusive devices which can have a primary shape of a coil of wire that is then formed into a more complex secondary shape, can be produced in such a way that they will pass through the lumen of a catheter in a linear shape and take on a complex shape as originally formed after being deployed into the area of interest, such as an aneurysm.
  • a variety of detachment mechanisms to release the device from a pusher have been developed and are known in the art.
  • micro-coils formed of very small diameter wire are used in order to restrict, reinforce, or to occlude such small diameter areas of the vasculature.
  • materials have been suggested for use in such micro-coils, including nickel-titanium alloys, copper, stainless steel, platinum, tungsten, various plastics or the like, each of which offers certain benefits in various applications.
  • Nickel-titanium alloys are particularly advantageous for the fabrication of such micro coils, in that they can have super-elastic or shape memory properties, and thus can be manufactured to easily fit into a linear portion of a catheter, but attain their originally formed, more complex shape when deployed. Although various materials are more or less kink resistant when nickel-titanium alloys are dimensioned into wire smaller than approximately 0.010 inches in diameter, they can have low yield strength and can kink more easily, thus severely limiting the applications for such finely drawn wire in the fabrication of vasoocclusive devices.
  • nickel-titanium alloys are also not radiopaque in small diameters, and a single nickel-titanium wire would need to be approximately 0.012 inches in diameter to be even slightly radiopaque.
  • a thickness of a single nickel-titanium wire would unfortunately also be relatively stiff and possibly traumatic to the placement site, particularly if used for treatment of delicate and already damaged areas of the small diameter vasculature such as an aneurysm in an artery or vein in the brain, for example.
  • a conventional guidewire for use in a catheter is known that is made of a high elasticity nickel-titanium alloy, and is useful for accessing peripheral or soft tissue targets.
  • the distal tip of the guidewire is provided with a radiopaque flexible coil tip, and a radiopaque end cap is attached to the guidewire by a radiopaque ribbon.
  • a stretch resistant vasoocclusive coil is also known that can be made of a primary helically wound coil of platinum wire, with a stretch-resisting wire attached within the primary coil between two end caps.
  • such a construction is relatively difficult to fabricate and also fragile, allowing for the possibility of the fracture of the central radiopaque wire, the coil, the welds or some combination of them, and it can also potentially break off during use. Also, such a construction has a complex and nonlinear bending characteristic, dependent on the spacing of the coils and central wire and the radius of the bend of the coil.
  • vasoocclusive devices and their attendant deployment systems provide important improvements in the treatment of damaged neurovascular areas.
  • a structural element that can be incorporated into a stent, guidewire, micro-coil or the like, which offers the advantages of a shape memory alloy such as a nickel-titanium alloy, and that incorporates radiopaque material in a stable configuration that is not subject to breaking during use of the device, so that the device can be visualized under fluoroscopy.
  • vasoocclusive devices take the form of spiral wound wires that can take more complex three dimensional shapes as they are inserted into the area to be treated.
  • wires can be installed in a micro-catheter in a relatively linear configuration and assume a more complex shape as it is forced from the distal end of the catheter.
  • shape memory materials such as nickel-titanium alloys have been incorporated in vasoocclusive devices to be placed by the catheters.
  • the range of diameters of wire and the configurations of the resulting geometry of both the coils and the devices developed which can be used have been limited by both the relatively small diameter of wire that must be used to avoid trauma and allow housing within the catheter prior to deployment, and the requirement for larger diameters to provide for radiopaque markers and mechanical robustness. In many cases this has resulted in primary wire characteristics in the coil that are unacceptably stiff, very delicate, or subject to kinking.
  • the present invention obtains significant advantages over such prior art devices by providing a cable of multiple strands of an alloy adapted to be used in catheters, stents, vasoocclusive devices, guidewires and the like, thus providing a kink resistant, high strength material with highly desirable performance characteristics which can be altered by construction details to suit a variety of interventional therapeutic procedures.
  • single strands of small diameter nickel-titanium alloys, as well as other metal alloys, used to form vasoocclusive devices can be kinked if twisted and pulled as can occur during or after deployment from a catheter, especially if the doctor wishes to withdraw a partially deployed coil because it is somehow incorrect in size, shape or length to repair the damage to the vessel.
  • single wire coils are more likely to cause trauma to the area to be treated if the wire is of a sufficient diameter to provide adequate tensile strength.
  • the present invention solves these and other problems by providing, in its broadest aspect, a micro-cable which includes at least one radiopaque strand to offer a continuous indication under fluoroscopy of the deployed configuration of the device incorporating the micro-cable.
  • a micro-cable which includes at least one radiopaque strand to offer a continuous indication under fluoroscopy of the deployed configuration of the device incorporating the micro-cable.
  • a presently preferred embodiment of the present invention provides for a multi-stranded micro-cable made of a suitable material such as stainless steel or a nickel-titanium alloy, with the cable including at least one radiopaque strand, made of platinum, tungsten or gold, in order to serve as a marker during a procedure.
  • the multi-stranded micro-cable can be configured into a stent, guidewire, micro-coil or the like used in micro-catheters, for example, to restrict, reinforce, or to occlude areas of the small diameter vasculature such as an artery or vein in the brain, for example, for treatment of aneurysms and the like.
  • the invention accordingly provides for a multi-stranded micro-cable formed of a plurality of flexible strands of a super elastic material, and at least one radiopaque strand.
  • the multi-stranded micro-cable comprises a plurality of flexible strands of nickel-titanium alloy, the micro-cable having at least one central axially disposed radiopaque wire, such as platinum, tungsten or gold, for example, in order to provide a radiopaque marker during vascular procedures.
  • the construction of the invention places the lowest tensile strength and highest flexibility member, the radiopaque marker strand, in a position in the cable which results in minimum stress on that member, at the same time, the super elastic material is in the outer strands, which have the dominant affect on performance parameters, thus enhancing the benefits of the material.
  • Another benefit associated with the invention compared to prior art devices is that the multiple stranded cable configuration, in addition to providing a highly flexible and resilient structure, eliminates the necessity of a safety wire, since the failure of a single strand will not cause a severing of the cable. Also, the construction prevents stretching of the cable in the event of failure of a single strand, which is a significant benefit compared to constructions which have a coil around a central safety wire.
  • the invention in a second presently preferred embodiment, includes a multi stranded cable constructed of multiple twisted strands of a suitable material such as a shape memory alloy or super elastic alloy of nickel-titanium, with one or more of the twisted strands consisting of a radiopaque material.
  • the radiopaque strand may be one or more of the peripheral twisted strands and may also include one or more central strands of the cable.
  • the cable consists of six peripheral twisted strands and a central linear core strand, one or more of which can be of radiopaque material.
  • the cable can be of linear strands that are arranged in a bundle and fastened or bound at intervals, or continuously, in order to maintain contact among the strands as the cable is bent.
  • One or more of the strands may be radiopaque.
  • This construction is adaptable to guidewires and other structures that must be pushable and/or torqueable, but still remain highly flexible and include radiopacity.
  • Variations on this embodiment can include an outer sheath which consists of a solid or helically wound cover to provide enhanced torqueability and pushability. More specifically, the outer sheath can vary in thickness, stiffness of material or spring of the sheath members to provide desired variations in bending or stiffness of the cable.
  • Such a construction is particularly adaptable to guidewires and the like, and can be varied in terms of the binding or outer layer to alter the torqueability of the cable, and the flexibility of the cable can be varied along its length by the number and sizes of the stranded members in the cable.
  • one or more of the strands can be of a therapeutic material used to enhance treatment of the site after placement of the device.
  • the cable includes twisted strands of wire around the periphery of the cable, at least one of which is radiopaque.
  • the core of the cable contains a therapeutic agent such as human growth hormone, genetic material, antigens or the like that are intended to become active after placement.
  • a therapeutic agent such as human growth hormone, genetic material, antigens or the like that are intended to become active after placement.
  • one of the strands can have multiple functions, such as providing both a therapeutic effect and also contributing to the structural integrity of the cable.
  • the copper can enhance the use of a device made from the cable as an intra-uterine device, with the copper also contributing to the radiopacity and structural integrity of the micro-cable.
  • the therapeutic strand can be placed on the exterior of the cable to enhance contact with the site to be treated.
  • a three dimensional occlusive device is provided that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, that comprises at least one multi-stranded micro-cable having a plurality of flexible strands of a resilient material, with at least one radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery.
  • the occlusive device is configured to have a primary, collapsed coil configuration or shape, and an expanded, or secondary three dimensional coil configuration or shape, that can be generally helical, conical, or spherical shapes.
  • the flexible strands in a multi-stranded micro-cable of the occlusive device can be helically wound, or can be configured as parallel, longitudinal strands.
  • at least one of the strands comprises a super-elastic material.
  • a plurality of the strands comprises a super-elastic material.
  • One presently preferred super-elastic material comprises a nickel titanium alloy, that can be heat treated such that the alloy is highly flexible at a temperature appropriate for introduction into the body via a catheter, and after placement, the device will seek its minimum energy shape as originally formed and thereby take on a shape designed to optimize the therapeutic purposes desired for the device.
  • At least one of the strands comprises a shape memory material.
  • a plurality of the strands are comprised of a shape memory material.
  • One presently preferred shape memory material comprises a shape memory polymer.
  • the strands of the micro-cable are arranged as exterior strands surrounding at least one interior strand, or core, and at least one radiopaque strand is disposed in the micro-cable, either centrally, axially disposed in the bundle of strands, or in the exterior strands surrounding the central core.
  • the micro-cable can include a plurality of radiopaque strands, such as platinum, gold, or tungsten.
  • At least one of the strands in the core or exterior strands can comprise a therapeutic agent, such as a copper or copper alloy wire or any of a variety of therapeutically active metals, alloys or components, a fiber such as Dacron (polyester), polyglycolic acid, polylactic acid, fluoropolymers, nylon, polyaramid fiber (e.g. Kevlar®), or silk chosen for thrombogenicity. Since the micro-cable consists of stranded parts, one or more strands may be longer than others, or even intermittently terminated, to thereby extend beyond the diameter of the remaining strands and thereby increase the therapeutic effect of that strand.
  • a therapeutic agent such as a copper or copper alloy wire or any of a variety of therapeutically active metals, alloys or components
  • a fiber such as Dacron (polyester), polyglycolic acid, polylactic acid, fluoropolymers, nylon, polyaramid fiber (e.g. Kevlar®), or silk chosen for thrombo
  • At least one of the strands can be coated with or impregnated with a therapeutic material, which can include, but is not limited to, any one or combination of human growth hormone, genetic material, antigens, hydrogels, collagen, bio-absorbable polymers such as lactic acids/glycolic acids, caprolactam or microcellular foam.
  • a therapeutic material can include, but is not limited to, any one or combination of human growth hormone, genetic material, antigens, hydrogels, collagen, bio-absorbable polymers such as lactic acids/glycolic acids, caprolactam or microcellular foam.
  • the therapeutic element can comprise a means to conduct energy, such as an optical fiber to conduct light energy.
  • the strands of the micro-cable can also be bundled by at least one outer cover or sheath to constrain the strands of the micro-cable about a longitudinal axis to produce a composite banded cable.
  • the outer sheath can comprise a containment strand wound about the strands and made of a low friction material, such as a fluoropolymer, for example, or a heat shrinkable plastic tube.
  • a plurality of heat shrink plastic covers are placed over the strands of the micro-cable to provide bending stiffness in the cable.
  • the strands of the micro-cable can be banded at intervals by a plurality of bands.
  • a plurality of micro-cables that are arranged as parallel, longitudinal micro-cables or a helically wound micro-cables to form a composite cable can have an exterior wrapped cover that can be wound at greater or lesser intervals along the outside to provide variations in the torqueability and stiffness of the composite cable.
  • the thickness and width of the wrapping cover, as well as its material composition along the composite cable can vary in cross section along the length of the composite cable to provide bending stiffness of said cable which varies with the position on said cable.
  • the number of strands and the degree to which they extend along the composite cable can be varied within the sheath, and the outer sheath itself can be multi-layered with different materials in order to provide a graduated bending and stiffness characteristic over the length of the cable.
  • the occlusive device thus can be formed of a plurality of micro-cables in order to provide desired bending and strength characteristics, either as helically wound micro-cables, or parallel longitudinal micro-cables having a collapsed composite cable configuration and an expanded composite cable configuration with a secondary shape.
  • the composite cable can further comprise at least one longitudinal sensing element for sensing a parameter, such as an optical imaging element, i.e., where the sensing element can comprises an optical fiber.
  • the sensing element can comprise a thermal imaging element, or an ultrasound imaging element, for example.
  • the form about which the three dimensional shape is wound is formed from metal, ceramic or other heat resistant material and has formed within it the path desired for the micro-cable corresponding to the shape.
  • the form can be of a spherical configuration, with the surface containing channels into which the cable is laid prior to heat treating.
  • the channels can be arranged so that the resultant shape is kink resistant and relatively easy to withdraw without kinking.
  • the form can also contain passages through which the cable can pass to advantageously form the shape.
  • the form and cable can be heat treated to cause the cable material to adopt the shape of the form as a low energy shape.
  • the cable can then be removed from the form and put into a catheter-introducer prior to use in intravascular therapy.
  • the invention comprises a device for use in interventional therapy and vascular surgery, adapted to be inserted into a portion of a vasculature, comprising a shape memory coil having an outer coil portion and an inner core portion, the shape memory coil having a collapsed primary coil configuration and an expanded secondary configuration with a three dimensional shape; and a radiopaque strand extending through the core of the shape memory coil to provide a radiopaque marker of the deployed configuration of the device.
  • the shape memory coil comprises a multi-stranded coil having a plurality of flexible strands of a resilient material
  • the shape memory coil comprises a single stranded coil, such as of a nickel titanium alloy, or a shape memory polymer, for example.
  • the radiopaque strand enhances the radiopacity of a multi-stranded coil as well as a single stranded coil of pure nickel titanium alloy, which will advantageously not fray upon stretching, and is stretch resistant.
  • the coil can also be made of other materials, such as a shape memory polymer such as polyurethane, for example.
  • the radiopaque strand comprises a core strand having a plurality of intermittently spaced apart enlarged radiopaque portions that can comprise a radiopaque material selected from the group consisting of platinum and gold, for example.
  • the core strand can comprise a material selected from the group consisting of platinum, gold, a shape memory polymer having a glass transition temperature (T g ) below 25° C., a hydrogel, an amorphous gel, and a fiber.
  • the enlarged radiopaque portions can comprise a plurality of beads of radiopaque material spaced apart and mounted on a core strand of material, and the beads may comprise a radiopaque material selected from the group consisting of platinum, gold and tungsten.
  • one or more of the plurality of beads can optionally be bonded to a segment of the shape memory coil, such as an end bead bonded to an end segment of the shape memory coil, for example.
  • the enlarged radiopaque portions may comprise a plurality of coils intermittently wound about and spaced apart on the core strand, and the core strand can comprise a radiopaque material selected from the group consisting of platinum and gold.
  • the spaced apart coils can comprise a radiopaque material selected from the group consisting of platinum and gold.
  • a polyhedral occlusive device adapted to be inserted into a portion of a vasculature for occluding a portion of the vasculature, for use in interventional therapy and vascular surgery.
  • the occlusive device can be formed with multiple coils centrally connected together at their inner ends to a central coil body and radiating outward from the central coil body.
  • the radiating coil arms of the occlusive device When inserted within a vessel at a treatment site, such as within an aneurysm, the radiating coil arms of the occlusive device extend to fill the vessel in three dimensions, allowing the occlusive device to accommodate the shape of the vessel.
  • the device for use in interventional therapy and vascular surgery includes a micro-cable or coil formed of one or more flexible strands of a resilient material, having a collapsed primary coil configuration and an expanded secondary configuration with a three dimensional shape; and one or more therapeutic fibers woven into the coil to enhance treatment of the site after placement of the device.
  • the coil can also be formed to include one or more radiopaque strands to provide a radiopaque marker of the deployed configuration of the device.
  • the one or more therapeutic fibers can be woven about adjacent or non-adjacent loops of the coil, or can be woven through multiple strands of adjacent loops of the coil.
  • the one or more therapeutic fibers are made of a material that will provide a timed release of a therapeutic agent intended to become active after placement of the device, such as human growth hormone, collagen, a modified polymer with growth factor, genetic material for gene therapy, antigens, or the like.
  • a therapeutic agent intended to become active after placement of the device
  • a plurality of therapeutic fibers can be provided so that the different fibers in the coil can provide different therapeutic agents to provide a range of therapies.
  • FIG. 1 is a perspective of a radiopaque microstrand cable constructed according to the invention.
  • FIG. 2 is a cross-section at 2 - 2 of FIG. 1 .
  • FIG. 3 is a helical vasoocclusive coil formed of the cable of the invention.
  • FIG. 4 is a spherical vasoocclusive structure formed using the cable of the invention.
  • FIG. 5 is a stacked coil vasoocclusive device formed using the cable of the invention.
  • FIG. 6 is a cross section of a vascular member with an aneurysm illustrating the approach of a vasoocclusive coil towards the aneurysm.
  • FIG. 7 is an illustration of a vasoocclusive coil which has been introduced into an aneurysm preparatory to being deployed within the aneurysm.
  • FIG. 8 is an illustration of a spherical vasoocclusive coil formed with cable of the invention deployed within an aneurysm.
  • FIG. 9 is an alternate in a preferred embodiment of the invention including a plurality of radiopaque strands within the cable.
  • FIG. 10 is an alternate preferred embodiment incorporating a therapeutic member within the radiopaque cable of the invention.
  • FIG. 11 is an alternate preferred embodiment of the present invention wherein strands of the cable are arranged within an exterior binding consisting of multiple straps about the cable.
  • FIG. 12 is a perspective view of the embodiment of FIG. 11 .
  • FIG. 13 is an alternative embodiment to the embodiment of FIG. 12 wherein the external binding of the cable represents a sheath wound about the cable.
  • FIGS. 14 a and 14 b are perspectives of alternative embodiments of the embodiment of FIG. 13 .
  • FIG. 15 is a cross-section of an alternative embodiment in which a plurality of multi-strand cables are included within an external sheath surrounding the cable.
  • FIG. 16 is a perspective view of the embodiment of FIG. 14 .
  • FIG. 17 is a plan view of a beaded radiopaque strand according to another preferred embodiment of the invention.
  • FIG. 18 is a sectional view of the beaded radiopaque strand of FIG. 17 inserted in a shape memory coil.
  • FIG. 19 is a plan view of an alternate preferred embodiment of a radiopaque strand with intermittent spaced apart coils.
  • FIG. 20 is a plan view of an alternate preferred embodiment of the radiopaque strand having spaced apart enlarged radiopaque portions.
  • FIG. 21 is a schematic diagram of a preferred three dimensional radiating coil configuration of a primary wind polyhedral occlusion device according to the principles of the invention.
  • FIG. 22 is a schematic diagram of an alternate preferred embodiment of a primary wind polyhedral occlusive device according to the principles of the invention.
  • FIG. 23 is a perspective view of a mandrel for forming the polyhedral occlusive device of FIG. 22 .
  • FIG. 24 is a schematic diagram of an alternate preferred embodiment of a secondary wind polyhedral occlusive device according to the principles of the invention.
  • FIG. 25 is a perspective view of another preferred alternate embodiment of a helical vasoocclusive coil according to the principles of the invention, with a therapeutic fiber woven around adjacent loops of the coil.
  • FIG. 26 is a perspective view of another preferred alternate embodiment of a helical vasoocclusive coil according to the principles of the invention, with a plurality of therapeutic fibers woven around adjacent loops of the coil.
  • FIG. 27 is a perspective view of another preferred alternate embodiment of a helical multi-stranded vasoocclusive coil according to the principles of the invention, with a therapeutic fiber woven through strands of adjacent loops of a multi-stranded coil.
  • FIG. 28 is a perspective view of another preferred alternate embodiment of a helical multi-stranded vasoocclusive coil according to the principles of the invention, with a plurality of therapeutic fibers woven through strands of adjacent loops of a multi-stranded coil.
  • micro-coils formed of very small diameter wires of nickel-titanium alloy material for treatment of areas of the small diameter vasculature such as an artery or vein in the brain, for treatment of aneurysms and the like, for example can have relatively low yield strengths and are somewhat subject to kinking, even if made of super-elastic alloy. This can create problems if the coil is to be withdrawn after being emplaced by the doctor, as for instance, if the device is too small to effectively fill the cavity to be treated. Furthermore, even solid wires of a size suitable for use in interventional devices are not very radiopaque.
  • the invention is embodied in a multi-stranded micro-cable formed of a plurality of flexible strands of a resilient material with the cable including at least one radiopaque strand.
  • the multi-stranded micro-cable 10 is approximately from 0.0015 to 0.009 inches in diameter, and comprises a plurality of flexible strands 12 of nickel-titanium alloy, with at least one centrally, axially disposed radiopaque wire 14 which is approximately from 0.0005 to 0.003 inches in diameter.
  • the central radiopaque wire 14 can be formed of platinum or gold, for example, or other similar suitable radiopaque metals, in order to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery.
  • the multi-strand cable construction of the invention allows the micro-wires of the cable to slip across each other and reinforce each other rather than break or take a set. Also, by incorporating a stranded radiopaque material such as platinum, tungsten or gold into the cable construction, the device is radiopaque in sizes much smaller than with other constructions.
  • the micro-cable construction of the invention can be used to produce soft, kink resistant, radiopaque stents, guidewires, guidewire distal tips, and micro-coils.
  • FIG. 2 is a cross-section of the micro-cable of FIG. 1 at 2 - 2 illustrating one presently preferred arrangement of the strands within the cable.
  • the exterior strands 12 are formed of a resilient material chosen to provide the characteristics desired for a specific application in interventional therapies.
  • this material is a nickel titanium super-elastic alloy which is heat treated such that the alloy is highly flexible at a temperature appropriate for introduction into the body via a catheter.
  • such a cable can have a central core 14 of a radiopaque material such as gold or platinum, thus dramatically enhancing the radiopacity of the cable.
  • a solid super-elastic wire of the same diameter as the cable would have substantially less radiopacity than the cable of the invention with the central gold or platinum wire and the construction of the invention provides numerous other highly desirable characteristics. Among these characteristics is the relative flexibility and resistance to kinking of the cable compared to an equivalent single wire and substantially greater accommodation of the cable to bending, etc., with resultant lessening of trauma to the surrounding tissue and ease of placement in a small body cavity.
  • FIG. 3 illustrates a helically wound coil 16 of micro-cable 10 which is formed to fit within a micro-catheter for insertion into an area upon which a therapeutic procedure is to be performed. While a helical coil is illustrated, it will be appreciated that numerous other secondary shapes can be formed from the cable of the invention, as will be described further below. More specifically, as illustrated in FIG.
  • a three dimensional, essentially spherical, device 18 can be formed of the cable 10 , (or even of a coil of the cable, if appropriate) at a temperature sufficient to heat treat the material and thereby create a memory of the desired shape.
  • the device is then inserted into a catheter from which it may be deployed into an aneurysm or the like.
  • the teachings of U.S. Pat. No. 5,645,558 describe the construction of such a device out of flexible wire and are incorporated by referenced herein.
  • FIG. 5 illustrates a collapsed coil configuration 20 for a vasoocclusive device which also can be formed from the cable of the invention and is used for the purposes of insertion into aneurysms and other defects that have relatively large entry necks compared to their internal volume.
  • FIG. 6 is an illustration of a catheter 22 using a coil 16 as a vasoocclusive device made of the present invention and used for insertion into an aneurysm 24 projecting laterally from a blood vessel 26 .
  • the coil 16 is contained within the outer housing 28 of a micro-catheter that is used to house the coil prior to deployment.
  • the end of the catheter housing 28 is introduced into the opening 30 of the aneurism 24 by use of a guide wire (note shown). Thereafter, the vasoocclusive coil 16 , and a pusher 32 are introduced into the catheter to provide for insertion of the vasoocclusive device into the aneurysm.
  • the coil 16 formed of the cable of the invention is retained to an optical fiber pusher 32 which is attached to the coil by a collar of shape memory plastic material 34 as described in co-pending application Ser. No. 08/986,004 the disclosure of which are incorporated herein by reference. As shown in FIG. 7 , the coil is introduced into the aneurysm and is then pushed from the micro-catheter until it fills the cavity.
  • vasoocclusive device must be withdrawn after it is fully or partly inserted into the aneurysm. In such a case, there is a danger that the coil will be stretched beyond its elastic range or kink, or otherwise deform and make withdrawal difficult.
  • vasoocclusive devices of secondary shapes which are based upon a basic configuration of a coil or the like. The present invention includes such applications within the scope of the invention. However, when vasoocclusive devices made of even super-elastic material are used, it is sometimes the case that the devices will be stretched or kinked when withdrawal is attempted.
  • the cable of the present invention substantially reduces the probability that kinking or stretching beyond yield will occur in a given instance, while at the same time providing radiopacity not available with other constructions. Thus, the present invention represents an important forward step in the technology of interventional therapy.
  • the shape memory collar 34 is heated to a temperature which allows it to be shrunk onto coil 16 .
  • the collar is attached to optical fiber pusher 32 by an adhesive 36 which retains high strength at temperatures beyond the shape memory material transition point.
  • light energy from a source of coherent light is introduced into the proximal end of the optical fiber (not shown) and propagated in the distal end 38 of the fiber to cause the shape memory material collar 34 to return to its previous shape and release coil 16 .
  • FIG. 8 illustrates an essentially spherical device 18 which has been deployed into such an aneurysm but it will commonly be found that a device such as that shown would then be supplemented by a further coiled device inserted within the space inside the spherical device to completely occlude flow from the artery to the aneurysm.
  • FIG. 9 is an example of one such construction 40 in which radiopacity is more desirable than in other forms and for that reason a number of radiopaque strands 42 , in this illustration four in number, are formed into the cable along with three resilient material strands 44 . It will also be appreciated that a larger or smaller number of strands may be incorporated into a given cable and the cables may be formed of multiple cables in order to provide desired bending and strength characteristics. It will also be appreciated by those skilled in the art that the invention is adaptable to the use of a variety of materials which by themselves would not have been easily adaptable to micro devices for interventional therapies.
  • composite cables incorporating one or more strands of a desired material can be configured with other strands providing strength, flexibility, shape memory, super-elasticity, radiopacity or the like for previously unavailable characteristics in micro devices.
  • FIG. 10 illustrates a cross-section of a further preferred embodiment in which radiopaque strands 42 and resilient strands 44 form a portion of the cable and a therapeutic agent 48 is contained in one of the strands.
  • a therapeutic agent can include human growth hormone, hydrogels, or a variety of other agents which will serve to provide desired therapeutic capabilities when placed within a specific area of the body being treated by use of the micro-catheter.
  • the agent strand may be placed in any of a variety of positions with the cable, from core wire outward.
  • one or more of the strands of the micro-cable is longer than the others, and perhaps intermittently terminated, to thereby produce a micro-cable in which the therapeutic strands extend to a greater diameter than the other strands to thus increase the therapeutic effect of the therapeutic stand.
  • Such a construction is particularly advantageous if increased thrombogenicity is desired, while maintaining structural continuity and radiopacity for the micro-cable.
  • FIG. 11 illustrates a cross-section of an additional presently preferred embodiment of the invention in which the strands 12 , 14 of the micro-cable 10 are bundled and banded at intervals by bands 50 to produce a composite banded cable 52 in order to provide increased flexibility without unraveling or dislocation of the strands in the cable.
  • FIG. 12 is a perspective view of the banded cable 50 of this embodiment. While the illustrated configuration shows the strands being laid parallel within the cable, it is also possible in this construction to include both twisted cables as the primary cables 10 within the outer bands 50 to form the composite cable 52 . This configuration can use one or more longitudinal strands 14 which are radiopaque, thus providing a continuous indication of radiopacity within the cable. As a further alternative embodiment, it is possible for the longitudinal cable 52 to be formed of a single inner cable 10 with bands 50 .
  • FIG. 13 illustrates a further embodiment of the invention in which longitudinal strands of cables are contained within a wound cover 56 for the purposes of providing a composite guide wire or the like 58 having improved torqueability.
  • a construction has particular advantages for guidewire designs having improved radiopacity in very small diameters. It will be appreciated that in this configuration, as well as the other longitudinally arranged multi-stranded cables, the number of strands and the degree to which they extend along the cable within the sheath is a variable which can be used to provide increased stiffness, pushability and torqueability in some sections with greater flexibility in others.
  • composite cables according to the invention can incorporate additional elements normally not available in solid guide wires, such as optical, thermal or ultrasound imaging elements, therapeutic agent delivery catheters, and can take advantage of materials which are not readily adaptable to prior art catheter or guide wire designs incorporating a primary wire structured element.
  • FIGS. 14 a and 14 b illustrate a further variable available because of the invention; the exterior wrapped cover 56 can be wound at greater or lesser intervals 60 along the outside to provide variations in the torqueability and stiffness of the composite cable.
  • the thickness and width of the wrapping cover 56 as well as its material composition along the composite guide wire 58 , can offer further capabilities for customizing the design for various applications.
  • FIG. 15 illustrates a cross-section of a micro-cable according to the invention which has at least one overall exterior sheath to contain the micro-cable.
  • the micro-cable may be made of one or more multiple strand elements which may further include twisted or longitudinal strands within their construction.
  • the sheath may also be used to control the torqueability characteristics of the cable and as discussed in co-pending application Ser. No. 08/986,004, the sheath may be multi-layered with different materials in order to provide a graduated bending and stiffness characteristic over the length of the cable.
  • a nickel titanium alloy coil such as the multi-stranded micro-cable described above, can be made radiopaque by the insertion of a radiopaque strand having spaced apart enlarged radiopaque portions into the core of a primary and/or secondary wind.
  • the radiopaque material preferably has a desired degree of stiffness so as not to compromise the desired degree of softness of the coil.
  • the material may comprise a beaded core of platinum, gold, shape memory polymer having a glass transition temperature (T g ) below 25° C., polymer, hydrogel, and the like, or a flexible strand, rod, amorphous gel, fiber, and the like.
  • the radiopaque strand can be used to enhance the radiopacity of the multi-stranded coil, as indicated above, as well as a pure nickel titanium alloy coil, which will advantageously not fray upon stretching, and is stretch resistant.
  • the coil can also be made of other materials, such as a polyurethane shape memory polymer, for example.
  • the radiopaque strand 70 may comprise a plurality of beads 72 of radiopaque material, such as platinum, gold or tungsten, spaced apart and mounted, such as by soldering, welding, or adhesive bonding such as by cyanoacrylate adhesive, on a core strand 74 of material that can be platinum, gold or tungsten, or a shape memory polymer having a glass transition temperature (T g ) below 25° C.
  • the beaded radiopaque strand can form the central core of a multi-stranded micro-cable, and as is shown in FIG.
  • the beaded radiopaque strand 70 may form a core of a pure nickel titanium alloy coil 76 wound around the beaded radiopaque strand, and having a proximal stem 77 bonded to the coil by soldering, welding, adhesive or the like, that can also be formed as a radiopaque marker, of such materials as platinum, gold or tungsten, for example.
  • one or more beads, such as an end bead 78 may optionally be bonded to a segment 80 of the coil, such as by cyanoacrylate adhesive 81 , for example.
  • the radiopaque strand can comprise a radiopaque wire 82 , such as platinum or gold, for example, intermittently wound with a plurality of spaced apart coils 84 of radiopaque material, such as platinum or gold, for example, to form an inner radiopaque core for a multi-stranded micro-cable, or in an alternate preferred embodiment, the intermittently wound radiopaque strand may form a core of a pure nickel titanium alloy coil wound around the intermittently wound radiopaque strand.
  • a radiopaque wire 82 such as platinum or gold
  • the intermittently wound radiopaque strand may form a core of a pure nickel titanium alloy coil wound around the intermittently wound radiopaque strand.
  • the radiopaque strand can comprise a radiopaque wire 86 , such as platinum or gold, for example, with intermittently spaced apart enlarged radiopaque portions 88 , to form an inner radiopaque core for a multi-stranded micro-cable, or for a pure nickel titanium alloy coil wound around the radiopaque strand.
  • a radiopaque wire 86 such as platinum or gold, for example, with intermittently spaced apart enlarged radiopaque portions 88 , to form an inner radiopaque core for a multi-stranded micro-cable, or for a pure nickel titanium alloy coil wound around the radiopaque strand.
  • a three dimensional occlusive device adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, can be formed as described above, from at least one multi-stranded micro-cable having a plurality of flexible strands of a resilient material, with at least one radiopaque strand to provide a radiopaque marker for the device during vascular surgery.
  • the occlusive device is configured to have a primary coil shape, as illustrated in FIG. 5 , and an expanded secondary three dimensional coil configuration or shape, that can be generally helical, conical, or spherical shapes, such as the spherical shapes illustrated in FIGS.
  • a mandrel suitable for making such three dimensionally shaped occlusive devices can be formed of a refractory material, such as alumina or zirconia, for example.
  • the mandrel typically has the general three dimensional shape that the occlusive device will be given, and can have a generally helical, conical, or spherical shape, or can have a unique shape designed to provide such a form to the occlusive device to fit a particular vascular structure to be treated.
  • the mandrel forms a support for the winding and heat treatment of the micro-cable, plurality of microcables, or composite micro-cable occlusive device as described above, and ideally will not contaminate the occlusive device during heat treatment of the device.
  • the surface of the mandrel preferably has a plurality of circumferential grooves for aligning the occlusive device as it is wound on the mandrel.
  • the surface of the mandrel may also have one or more apertures for receiving one or more ends of the micro-cable, plurality of microcables, or composite micro-cable, to assist winding into the desired form.
  • the wound occlusive device is then heat treated at a suitable temperature and a sufficient period of time to impart the form to the shape memory material included in the device. While heat treatment at a temperature of about 1100° F. for approximately 4 hours or more is typically sufficient to impart the form to the occlusive device when the shape memory material is a nickel titanium super-elastic alloy, but when the occlusive device includes fibers or a therapeutic agent that can be affected by heat, the temperature utilized can be substantially lowered, and the duration of heat treatment adjusted accordingly, as will be appreciated by those skilled in the art. Alternatively, if the therapeutic agent is not amenable to elevated temperatures, it may be added after formation of the three dimensional shape.
  • the occlusive device After the heat treatment, the occlusive device is removed from the mandrel, and cold worked into the desired collapsed primary configuration for placement into a catheter or cannula for use. It will be appreciated that those techniques can also be used for a variety of cables produced according to the invention, including those which use shape memory materials other than nickel-titanium alloys.
  • the occlusive device When the occlusive device reaches its destination in the vasculature during vascular therapy, it assumes the secondary relaxed and expanded three dimensional shape imparted from the heat treatment on the mandrel.
  • a three dimensional, polyhedral occlusive device is provided, adapted to be inserted into a portion of a vasculature for occluding a portion of the vasculature, for use in interventional therapy and vascular surgery.
  • the occlusive device can be formed as described above, from at least one multi-stranded micro-cable having a plurality of flexible strands of a resilient material, with at least one radiopaque strand to provide a radiopaque marker for the device during vascular surgery, with multiple coils, preferably four or more coils, centrally connected together at their inner ends, and in a presently preferred aspect, connected at their inner ends to a central coil body and radiating outward from the central coil body.
  • the radiating coil arms of the occlusive device When inserted with a vessel at a treatment site, such as within an aneurysm, the radiating coil arms of the occlusive device extend to fill the vessel in three dimensions, allowing the occlusive device to accommodate the shape of the vessel.
  • the radiating coils of the occlusive device can thus form a tetrahedral, pentahedral, hexahedral, or other polyhedral shape, symmetrical or unsymmetrical, and are preferably formed from conically shaped coil arms that have an expanding diameter as they radiate outward from the central coil body, with the radiating coil arms having soft larger diameter outer ends.
  • the central coil body may be spherical or rounded, or may be correspondingly cubical, tetrahedral, pentahedral, or otherwise appropriately polyhedral.
  • a typical aneurysm may have a diameter of approximately 10 mm., and the coil arms will also typically have an outer diameter of approximately 10 mm.
  • one presently preferred three dimensional radiating coil configuration 90 is a primary wind coil having a hexahedral configuration with six conically shaped coil arms 92 radiating from a central coil junction 94 in the three x, y and z axes of a three dimensional pattern of coordinates.
  • Such a three dimensional radiating coil configuration can be formed by individually winding the radiating arms of the hexahedral configuration on conically shaped mandrel, and bonding the inner apical ends 96 of the coils together by welding, solder, adhesive such as cyanoacrylate, or the like.
  • a central coil body 98 such as the spherical coil described above is also preferably similarly bonded to the inner ends of the coil arms.
  • a three dimensional radiating hexahedral coil configuration 100 for the occlusive device is also a primary wind coil with six conically shaped coils or coil arms 102 radiating from a central coil ball or sphere 104 in the three x, y and z axes forming a three dimensional pattern of coordinates.
  • the central ball may also alternatively have the shape of a cube, for example.
  • the outer diameter of the coil arms typically can be approximately 10 mm., and the diameter of the central coil ball or sphere typically can be 3 mm. in diameter.
  • the hexahedral coil can be formed by winding the central spherical coil about a mandrel as described above and then joining the six radiating conical coil arms at their inner apical ends 106 to the central spherical coil 108 , as described above, such as by welding, solder, adhesive such as cyanoacrylate, or the like.
  • the hexahedral coil configuration can be formed as a continuous primary wind of the coil by winding the central spherical coil, and forming the radiating arms by a double winding of the radiating conical coil arms, first up from the center and then back down, with each of the radiating conical coil arms being wound in turn about the central spherical at the appropriate location.
  • such a hexahedral configuration with six conically shaped coils radiating from a common central coil ball or sphere can be formed by winding the coils about a mandrel 110 formed of a refractory material, such as alumina or zirconia, for example, and having inverted conical coil arms 112 radiating from a central body 114 , such as a spherical, rounded, cubical, tetrahedral, pentahedral or otherwise polyhedral central body, for example.
  • a central body 114 such as a spherical, rounded, cubical, tetrahedral, pentahedral or otherwise polyhedral central body, for example.
  • the mandrel forms a support for the winding and heat treatment of the three dimensional radiating hexahedral coil occlusive device as described above, and ideally will not contaminate the occlusive device during heat treatment of the device.
  • the surface of the central body of the mandrel preferably has a plurality of circumferential grooves 116 for aligning the occlusive device as it is wound on the mandrel.
  • the surface of the mandrel may also have one or more apertures 118 for receiving one or more ends of the micro-cable, plurality of microcables, or composite micro-cable forming the hexahedral occlusive device, to assist winding into the desired form.
  • a another presently preferred alternate three dimensional radiating coil configuration 120 is a secondary wind coil of a primary wind coil, such as a helical wind, for example, the secondary wind coil having a hexahedral configuration with six conically shaped-coil arms 122 radiating from the common central coil 124 , which is illustrated as having a cubical shape, in the three x, y and z axes of a three dimensional pattern of coordinates.
  • the outer diameter of the coil arms typically can be approximately 10 mm., and the diameter of the central coil ball or sphere typically can be 3 mm. in diameter.
  • the hexahedral secondary wind configuration can be formed by winding the primary helical wind coil about an appropriate mandrel, and then joining the six radiating conical coil arms at their inner apical ends 126 to the common central coil 128 , as described above, such as by welding, solder, adhesive such as cyanoacrylate, or the like.
  • the hexahedral coil configuration can be formed as a continuous primary wind of the coil by winding the central coil body, and forming the radiating arms by a double winding of the radiating conical coil arms, first up from the center and then back down, with each of the radiating conical coil arms being wound in turn about the central spherical at the appropriate location.
  • the tetrahedral, pentahedral, hexahedral or other polyhedral wound occlusive device radiating from the common central coil is then preferably heat treated upon the mandrel at a suitable temperature and for a sufficient period of time to impart the relaxed form to the shape memory material forming the device.
  • the occlusive device can then be cold worked into a shape suitable for delivery through a catheter to a desired treatment site, and when the occlusive device reaches its destination in the vasculature during vascular therapy, it assumes the relaxed and expanded three dimensional shape imparted from the heat treatment on the mandrel.
  • a helical microcoil 130 that can be formed of one or more flexible strands of nickel-titanium alloy, has one or more therapeutic fibers 136 advantageously woven about adjacent loops of the coil, used to enhance treatment of the site after placement of the device.
  • the helical microcoil can also be formed to include one or more axially disposed radiopaque wires, as described above.
  • the one or more therapeutic fibers can be woven about non-adjacent loops of the coil as well.
  • the therapeutic fibers are preferably made of a material that will provide a timed release of a therapeutic agent, such as human growth hormone, collagen, a modified polymer with growth factor, genetic material for gene therapy, antigens or the like, that are intended to become active after placement.
  • a therapeutic agent such as human growth hormone, collagen, a modified polymer with growth factor, genetic material for gene therapy, antigens or the like.
  • different fibers can be provided in the same coil with different therapeutic agents to provide different therapies.
  • the fibers are preferably woven into the coil by hand after the heat setting of the coil shape.
  • a helical microcoil 140 formed of a plurality of flexible strands 142 of nickel-titanium alloy, with at least one centrally, axially disposed radiopaque wire 144 as described above has one or more therapeutic fibers 136 as described above, advantageously woven through the multiple strands of adjacent loops of the coil, to enhance treatment of the site after placement of the device.
  • the one or more therapeutic fibers can be woven through the strands of non-adjacent loops of the coil as well.
  • the different fibers can be provided in the same coil with different therapeutic agents to provide different therapies.
  • the one or more fibers are preferably woven through the strands of the multiply-stranded microcoil by hand during winding of the multiply-stranded microcoil.

Abstract

The three-dimensional device is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery. The device is formed from a multi-stranded micro-cable having a plurality of flexible strands of a shape memory material and at least one radiopaque strand. The flexible strands in a multi-stranded micro-cable of the device can be helically wound, or can be configured as parallel, longitudinal strands, and can also be formed to have a secondary, three-dimensional therapeutic configuration, such as helical, conical, spherical, or other geometric shapes. The strands can be made of a shape memory nickel titanium alloy, that is highly flexible at a temperature appropriate for introduction into the body via a catheter, and that after placement will take on the therapeutic shape. The device can also include a therapeutic agent, and can be bundled by an outer cover to constrain the strands of the micro-cable about a longitudinal axis to produce a composite banded cable. The radiopaque strand can have a core strand with a plurality of intermittently spaced apart enlarged radiopaque portions that may be a plurality of beads of radiopaque material spaced apart and mounted on the core strand, or a plurality of coils intermittently wound about and spaced apart on the core strand. A polyhedral occlusive device is also provided, adapted to be inserted into a portion of a vasculature for occluding a portion of the vasculature, for use in interventional therapy and vascular surgery. One or more therapeutic fibers can also be woven into the coil to enhance treatment of the side after placement of the device.

Description

    RELATED APPLICATIONS
  • This is a continuation-in-part of Ser. No. 09/019,841 filed Feb. 6, 1998, which was a continuation-in-part of Ser. No. 08/986,004 filed Dec. 5, 1997.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • This invention relates generally to implantable devices for interventional therapeutic treatment or vascular surgery, and concerns a stranded micro-cable with enhanced radiopacity that can be used to fabricate a vascular device, a stent, a guidewire or the like. More particularly, the invention relates to three dimensional microcoil vasoocclusive devices fabricated from stranded micro-cable.
  • 2. Description of Related Art
  • The art and science of interventional therapy and surgery has continually progressed towards treatment of internal defects and diseases by use of ever smaller incisions or access through the vasculature or body openings, in order to reduce the trauma to tissue surrounding the treatment site. One important aspect of such treatments involves the use of catheters to place therapeutic devices at a treatment site by access through the vasculature. Examples of such procedures include transluminal angioplasty, placement of stents to reinforce the walls of a blood vessel or the like and the use of vasoocclusive devices to treat defects in the vasculature. There is a constant drive by those practicing in the art to develop new and more capable systems for such applications. When coupled with developments in biological treatment capabilities, there is an expanding need for technologies that enhance the performance of interventional therapeutic devices and systems.
  • One specific field of interventional therapy that has been able to advantageously use recent developments in technology is the treatment of neurovascular defects. More specifically, as smaller and more capable structures and materials have been developed, treatment of vascular defects in the human brain which were previously untreatable or represented unacceptable risks via conventional surgery have become amenable to treatment. One type of non-surgical therapy that has become advantageous for the treatment of defects in the neurovasculature has been the placement by way of a catheter of vasoocclusive devices in a damaged portion of a vein or artery.
  • Vasoocclusion devices are therapeutic devices that are placed within the vasculature of the human body, typically via a catheter, either to block the flow of blood through a vessel making up that portion of the vasculature through the formation of an embolus or to form such an embolus within an aneurysm stemming from the vessel. The vasoocclusive devices can take a variety of configurations, and are generally formed of one or more elements that are larger in the deployed configuration than when they are within the delivery catheter prior to placement. One widely used vasoocclusive device is a helical wire coil having a deployed configuration which may be dimensioned to engage the walls of the vessels. One anatomically shaped vasoocclusive device that forms itself into a shape of an anatomical cavity such as an aneurysm and is made of a pre-formed strand of flexible material that can be a nickel-titanium alloy is known from U.S. Pat. No. 5,645,558, which is specifically incorporated by reference herein. That vasoocclusive device comprises one or more vasoocclusive members wound to form a generally spherical or ovoid shape in a relaxed state. The vasoocclusive members can be a helically wound coil or a co-woven braid formed of a biocompatible material, and the device is sized and shaped to fit within a vascular cavity or vesicle, such as for treatment of an aneurysm or fistula. The vasoocclusive member can be first helically wound or braided in a generally linear fashion, and is then wound around an appropriately shaped mandrel or form, and heat treated to retain the shape after removal from the heating form. Radiopacity can be provided in the vasoocclusive members by weaving in synthetic or natural fibers filled with powdered radiopaque material, such as powdered tantalum, powdered tungsten, powdered bismuth oxide or powdered barium sulfate, which can potentially be released during vascular surgery.
  • Another occlusion device for closing defects in vascular walls is known that is formed by a pair of distinct sections of varying configuration, which may be parabolic or conical bodies oriented to flare outward. Yet another implantable vasoocclusive device is known that is formed by a complex, helically wound coil adapted to take on a secondary shape suitable for snugly fitting within a given vascular cavity upon deployment, that can be formed by winding the coil on a mandrel having radially extending poles.
  • The delivery of such vasoocclusive devices can be accomplished by a variety of means, including via a catheter in which the device is pushed through the catheter by a pusher to deploy the device. The vasoocclusive devices, which can have a primary shape of a coil of wire that is then formed into a more complex secondary shape, can be produced in such a way that they will pass through the lumen of a catheter in a linear shape and take on a complex shape as originally formed after being deployed into the area of interest, such as an aneurysm. A variety of detachment mechanisms to release the device from a pusher have been developed and are known in the art.
  • For treatment of areas of the small diameter vasculature such as a small artery or vein in the brain, for example, and for treatment of aneurysms and the like, micro-coils formed of very small diameter wire are used in order to restrict, reinforce, or to occlude such small diameter areas of the vasculature. A variety of materials have been suggested for use in such micro-coils, including nickel-titanium alloys, copper, stainless steel, platinum, tungsten, various plastics or the like, each of which offers certain benefits in various applications. Nickel-titanium alloys are particularly advantageous for the fabrication of such micro coils, in that they can have super-elastic or shape memory properties, and thus can be manufactured to easily fit into a linear portion of a catheter, but attain their originally formed, more complex shape when deployed. Although various materials are more or less kink resistant when nickel-titanium alloys are dimensioned into wire smaller than approximately 0.010 inches in diameter, they can have low yield strength and can kink more easily, thus severely limiting the applications for such finely drawn wire in the fabrication of vasoocclusive devices. As a further limitation to such applications, nickel-titanium alloys are also not radiopaque in small diameters, and a single nickel-titanium wire would need to be approximately 0.012 inches in diameter to be even slightly radiopaque. However, such a thickness of a single nickel-titanium wire would unfortunately also be relatively stiff and possibly traumatic to the placement site, particularly if used for treatment of delicate and already damaged areas of the small diameter vasculature such as an aneurysm in an artery or vein in the brain, for example.
  • One conventional guidewire for use in a catheter is known that is made of a high elasticity nickel-titanium alloy, and is useful for accessing peripheral or soft tissue targets. The distal tip of the guidewire is provided with a radiopaque flexible coil tip, and a radiopaque end cap is attached to the guidewire by a radiopaque ribbon. Such a construction is complex to manufacture, fragile and can potentially break off during use with undesirable results. A stretch resistant vasoocclusive coil is also known that can be made of a primary helically wound coil of platinum wire, with a stretch-resisting wire attached within the primary coil between two end caps. Unfortunately, such a construction is relatively difficult to fabricate and also fragile, allowing for the possibility of the fracture of the central radiopaque wire, the coil, the welds or some combination of them, and it can also potentially break off during use. Also, such a construction has a complex and nonlinear bending characteristic, dependent on the spacing of the coils and central wire and the radius of the bend of the coil.
  • From the above, it can be seen that vasoocclusive devices and their attendant deployment systems provide important improvements in the treatment of damaged neurovascular areas. However, there remain important limitations in the technology presently available to fabricate these devices. It would therefore be desirable to provide a structural element that can be incorporated into a stent, guidewire, micro-coil or the like, which offers the advantages of a shape memory alloy such as a nickel-titanium alloy, and that incorporates radiopaque material in a stable configuration that is not subject to breaking during use of the device, so that the device can be visualized under fluoroscopy. It would also be desirable to be able to create a variety of three dimensional vasoocclusive shapes that can be deployed from a catheter into an aneurysm or other defect and to thereby provide an efficient therapy for treatment of the defect. The present invention meets these and other needs.
  • SUMMARY OF THE INVENTION
  • Significant advances have been made in the treatment of neurovascular defects without resolution to surgery. More specifically, micro catheters have been developed which allow the placement of vasoocclusive devices in an area of the vasculature which has been damaged. In presently used techniques, the vasoocclusive devices take the form of spiral wound wires that can take more complex three dimensional shapes as they are inserted into the area to be treated. By using materials that are highly flexible, or even super-elastic and relatively small in diameter, the wires can be installed in a micro-catheter in a relatively linear configuration and assume a more complex shape as it is forced from the distal end of the catheter.
  • In order to gain the advantages presently being realized with micro-catheter therapies and procedures to repair damage to the vasculature in the brain and other vessels, shape memory materials such as nickel-titanium alloys have been incorporated in vasoocclusive devices to be placed by the catheters. However, the range of diameters of wire and the configurations of the resulting geometry ofboth the coils and the devices developed which can be used have been limited by both the relatively small diameter of wire that must be used to avoid trauma and allow housing within the catheter prior to deployment, and the requirement for larger diameters to provide for radiopaque markers and mechanical robustness. In many cases this has resulted in primary wire characteristics in the coil that are unacceptably stiff, very delicate, or subject to kinking. The present invention obtains significant advantages over such prior art devices by providing a cable of multiple strands of an alloy adapted to be used in catheters, stents, vasoocclusive devices, guidewires and the like, thus providing a kink resistant, high strength material with highly desirable performance characteristics which can be altered by construction details to suit a variety of interventional therapeutic procedures.
  • More specifically, it has been found that single strands of small diameter nickel-titanium alloys, as well as other metal alloys, used to form vasoocclusive devices can be kinked if twisted and pulled as can occur during or after deployment from a catheter, especially if the doctor wishes to withdraw a partially deployed coil because it is somehow incorrect in size, shape or length to repair the damage to the vessel. Also, single wire coils are more likely to cause trauma to the area to be treated if the wire is of a sufficient diameter to provide adequate tensile strength. Furthermore, such small diameter wires of some of these materials such as nickel-titanium, stainless steel and the like, are not generally radiopaque with currently available equipment, necessitating the use of radiopaque markers attached to the device, with the resultant possible diminution of functionality and increased diameter.
  • The present invention solves these and other problems by providing, in its broadest aspect, a micro-cable which includes at least one radiopaque strand to offer a continuous indication under fluoroscopy of the deployed configuration of the device incorporating the micro-cable. When combined with the benefits of a material such as nickel-titanium in the other strands of the micro-cable, numerous advantages are available from the use of this basic construction in interventional medicine.
  • Briefly, and in general terms, a presently preferred embodiment of the present invention provides for a multi-stranded micro-cable made of a suitable material such as stainless steel or a nickel-titanium alloy, with the cable including at least one radiopaque strand, made of platinum, tungsten or gold, in order to serve as a marker during a procedure. The multi-stranded micro-cable can be configured into a stent, guidewire, micro-coil or the like used in micro-catheters, for example, to restrict, reinforce, or to occlude areas of the small diameter vasculature such as an artery or vein in the brain, for example, for treatment of aneurysms and the like.
  • In one presently preferred embodiment, the invention accordingly provides for a multi-stranded micro-cable formed of a plurality of flexible strands of a super elastic material, and at least one radiopaque strand. In one presently preferred embodiment, the multi-stranded micro-cable comprises a plurality of flexible strands of nickel-titanium alloy, the micro-cable having at least one central axially disposed radiopaque wire, such as platinum, tungsten or gold, for example, in order to provide a radiopaque marker during vascular procedures. In this preferred embodiment, the construction of the invention places the lowest tensile strength and highest flexibility member, the radiopaque marker strand, in a position in the cable which results in minimum stress on that member, at the same time, the super elastic material is in the outer strands, which have the dominant affect on performance parameters, thus enhancing the benefits of the material. Another benefit associated with the invention compared to prior art devices is that the multiple stranded cable configuration, in addition to providing a highly flexible and resilient structure, eliminates the necessity of a safety wire, since the failure of a single strand will not cause a severing of the cable. Also, the construction prevents stretching of the cable in the event of failure of a single strand, which is a significant benefit compared to constructions which have a coil around a central safety wire.
  • In a second presently preferred embodiment, the invention includes a multi stranded cable constructed of multiple twisted strands of a suitable material such as a shape memory alloy or super elastic alloy of nickel-titanium, with one or more of the twisted strands consisting of a radiopaque material. The radiopaque strand may be one or more of the peripheral twisted strands and may also include one or more central strands of the cable. In a preferred aspect of the embodiment, the cable consists of six peripheral twisted strands and a central linear core strand, one or more of which can be of radiopaque material.
  • In a third aspect of the invention, the cable can be of linear strands that are arranged in a bundle and fastened or bound at intervals, or continuously, in order to maintain contact among the strands as the cable is bent. One or more of the strands may be radiopaque. This construction is adaptable to guidewires and other structures that must be pushable and/or torqueable, but still remain highly flexible and include radiopacity. Variations on this embodiment can include an outer sheath which consists of a solid or helically wound cover to provide enhanced torqueability and pushability. More specifically, the outer sheath can vary in thickness, stiffness of material or spring of the sheath members to provide desired variations in bending or stiffness of the cable. Such a construction is particularly adaptable to guidewires and the like, and can be varied in terms of the binding or outer layer to alter the torqueability of the cable, and the flexibility of the cable can be varied along its length by the number and sizes of the stranded members in the cable.
  • In a fourth aspect of the invention, one or more of the strands can be of a therapeutic material used to enhance treatment of the site after placement of the device. In one presently preferred embodiment of the invention, the cable includes twisted strands of wire around the periphery of the cable, at least one of which is radiopaque. The core of the cable contains a therapeutic agent such as human growth hormone, genetic material, antigens or the like that are intended to become active after placement. Such a construction can be adapted to a variety of interventional therapeutic treatments. In one aspect of this embodiment, one of the strands can have multiple functions, such as providing both a therapeutic effect and also contributing to the structural integrity of the cable. By using copper in such a micro-cable, for instance, the copper can enhance the use of a device made from the cable as an intra-uterine device, with the copper also contributing to the radiopacity and structural integrity of the micro-cable. In the event that such an effect is desired, the therapeutic strand can be placed on the exterior of the cable to enhance contact with the site to be treated.
  • In a fifth aspect of the invention, a three dimensional occlusive device is provided that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, that comprises at least one multi-stranded micro-cable having a plurality of flexible strands of a resilient material, with at least one radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery. The occlusive device is configured to have a primary, collapsed coil configuration or shape, and an expanded, or secondary three dimensional coil configuration or shape, that can be generally helical, conical, or spherical shapes. The flexible strands in a multi-stranded micro-cable of the occlusive device can be helically wound, or can be configured as parallel, longitudinal strands. In a currently preferred embodiment, at least one of the strands comprises a super-elastic material. In another currently preferred embodiment, a plurality of the strands comprises a super-elastic material. One presently preferred super-elastic material comprises a nickel titanium alloy, that can be heat treated such that the alloy is highly flexible at a temperature appropriate for introduction into the body via a catheter, and after placement, the device will seek its minimum energy shape as originally formed and thereby take on a shape designed to optimize the therapeutic purposes desired for the device.
  • In another aspect of the invention, at least one of the strands comprises a shape memory material. In another currently preferred embodiment, a plurality of the strands are comprised of a shape memory material. One presently preferred shape memory material comprises a shape memory polymer. In one configuration, the strands of the micro-cable are arranged as exterior strands surrounding at least one interior strand, or core, and at least one radiopaque strand is disposed in the micro-cable, either centrally, axially disposed in the bundle of strands, or in the exterior strands surrounding the central core. The micro-cable can include a plurality of radiopaque strands, such as platinum, gold, or tungsten.
  • In the fifth aspect of the invention, at least one of the strands in the core or exterior strands can comprise a therapeutic agent, such as a copper or copper alloy wire or any of a variety of therapeutically active metals, alloys or components, a fiber such as Dacron (polyester), polyglycolic acid, polylactic acid, fluoropolymers, nylon, polyaramid fiber (e.g. Kevlar®), or silk chosen for thrombogenicity. Since the micro-cable consists of stranded parts, one or more strands may be longer than others, or even intermittently terminated, to thereby extend beyond the diameter of the remaining strands and thereby increase the therapeutic effect of that strand. Alternatively, at least one of the strands can be coated with or impregnated with a therapeutic material, which can include, but is not limited to, any one or combination of human growth hormone, genetic material, antigens, hydrogels, collagen, bio-absorbable polymers such as lactic acids/glycolic acids, caprolactam or microcellular foam. In addition, the therapeutic element can comprise a means to conduct energy, such as an optical fiber to conduct light energy.
  • In the fifth aspect of the invention, the strands of the micro-cable can also be bundled by at least one outer cover or sheath to constrain the strands of the micro-cable about a longitudinal axis to produce a composite banded cable. The outer sheath can comprise a containment strand wound about the strands and made of a low friction material, such as a fluoropolymer, for example, or a heat shrinkable plastic tube. In one feature of the fifth aspect of the invention, a plurality of heat shrink plastic covers are placed over the strands of the micro-cable to provide bending stiffness in the cable. The strands of the micro-cable can be banded at intervals by a plurality of bands. In another variation, a plurality of micro-cables that are arranged as parallel, longitudinal micro-cables or a helically wound micro-cables to form a composite cable can have an exterior wrapped cover that can be wound at greater or lesser intervals along the outside to provide variations in the torqueability and stiffness of the composite cable. Also, the thickness and width of the wrapping cover, as well as its material composition along the composite cable can vary in cross section along the length of the composite cable to provide bending stiffness of said cable which varies with the position on said cable. Also, the number of strands and the degree to which they extend along the composite cable can be varied within the sheath, and the outer sheath itself can be multi-layered with different materials in order to provide a graduated bending and stiffness characteristic over the length of the cable. The occlusive device thus can be formed of a plurality of micro-cables in order to provide desired bending and strength characteristics, either as helically wound micro-cables, or parallel longitudinal micro-cables having a collapsed composite cable configuration and an expanded composite cable configuration with a secondary shape. In another feature of the fifth aspect of the invention, the composite cable can further comprise at least one longitudinal sensing element for sensing a parameter, such as an optical imaging element, i.e., where the sensing element can comprises an optical fiber. Alternatively, the sensing element can comprise a thermal imaging element, or an ultrasound imaging element, for example.
  • In a further aspect of the invention, the form about which the three dimensional shape is wound is formed from metal, ceramic or other heat resistant material and has formed within it the path desired for the micro-cable corresponding to the shape. For example, the form can be of a spherical configuration, with the surface containing channels into which the cable is laid prior to heat treating. The channels can be arranged so that the resultant shape is kink resistant and relatively easy to withdraw without kinking. The form can also contain passages through which the cable can pass to advantageously form the shape.
  • After the cable is wound around the form, the form and cable can be heat treated to cause the cable material to adopt the shape of the form as a low energy shape. The cable can then be removed from the form and put into a catheter-introducer prior to use in intravascular therapy.
  • In another presently preferred embodiment, the invention comprises a device for use in interventional therapy and vascular surgery, adapted to be inserted into a portion of a vasculature, comprising a shape memory coil having an outer coil portion and an inner core portion, the shape memory coil having a collapsed primary coil configuration and an expanded secondary configuration with a three dimensional shape; and a radiopaque strand extending through the core of the shape memory coil to provide a radiopaque marker of the deployed configuration of the device. In one presently preferred embodiment, the shape memory coil comprises a multi-stranded coil having a plurality of flexible strands of a resilient material, and in an alternate preferred embodiment, the shape memory coil comprises a single stranded coil, such as of a nickel titanium alloy, or a shape memory polymer, for example. The radiopaque strand enhances the radiopacity of a multi-stranded coil as well as a single stranded coil of pure nickel titanium alloy, which will advantageously not fray upon stretching, and is stretch resistant. With such an inner radiopaque strand, the coil can also be made of other materials, such as a shape memory polymer such as polyurethane, for example.
  • In a presently preferred embodiment, the radiopaque strand comprises a core strand having a plurality of intermittently spaced apart enlarged radiopaque portions that can comprise a radiopaque material selected from the group consisting of platinum and gold, for example. The core strand can comprise a material selected from the group consisting of platinum, gold, a shape memory polymer having a glass transition temperature (Tg) below 25° C., a hydrogel, an amorphous gel, and a fiber. In one presently preferred aspect, the enlarged radiopaque portions can comprise a plurality of beads of radiopaque material spaced apart and mounted on a core strand of material, and the beads may comprise a radiopaque material selected from the group consisting of platinum, gold and tungsten. In another presently preferred aspect, one or more of the plurality of beads can optionally be bonded to a segment of the shape memory coil, such as an end bead bonded to an end segment of the shape memory coil, for example.
  • In another presently preferred aspect, the enlarged radiopaque portions may comprise a plurality of coils intermittently wound about and spaced apart on the core strand, and the core strand can comprise a radiopaque material selected from the group consisting of platinum and gold. The spaced apart coils can comprise a radiopaque material selected from the group consisting of platinum and gold.
  • In another presently preferred embodiment, a polyhedral occlusive device is provided, adapted to be inserted into a portion of a vasculature for occluding a portion of the vasculature, for use in interventional therapy and vascular surgery. The occlusive device can be formed with multiple coils centrally connected together at their inner ends to a central coil body and radiating outward from the central coil body. When inserted within a vessel at a treatment site, such as within an aneurysm, the radiating coil arms of the occlusive device extend to fill the vessel in three dimensions, allowing the occlusive device to accommodate the shape of the vessel.
  • In another presently preferred embodiment, the device for use in interventional therapy and vascular surgery includes a micro-cable or coil formed of one or more flexible strands of a resilient material, having a collapsed primary coil configuration and an expanded secondary configuration with a three dimensional shape; and one or more therapeutic fibers woven into the coil to enhance treatment of the site after placement of the device. The coil can also be formed to include one or more radiopaque strands to provide a radiopaque marker of the deployed configuration of the device. The one or more therapeutic fibers can be woven about adjacent or non-adjacent loops of the coil, or can be woven through multiple strands of adjacent loops of the coil. The one or more therapeutic fibers are made of a material that will provide a timed release of a therapeutic agent intended to become active after placement of the device, such as human growth hormone, collagen, a modified polymer with growth factor, genetic material for gene therapy, antigens, or the like. A plurality of therapeutic fibers can be provided so that the different fibers in the coil can provide different therapeutic agents to provide a range of therapies.
  • These and other aspects and advantages of the invention will become apparent from the following detailed description and the accompanying drawings, which illustrate by way of example the features of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective of a radiopaque microstrand cable constructed according to the invention.
  • FIG. 2 is a cross-section at 2-2 of FIG. 1.
  • FIG. 3 is a helical vasoocclusive coil formed of the cable of the invention.
  • FIG. 4 is a spherical vasoocclusive structure formed using the cable of the invention.
  • FIG. 5 is a stacked coil vasoocclusive device formed using the cable of the invention.
  • FIG. 6 is a cross section of a vascular member with an aneurysm illustrating the approach of a vasoocclusive coil towards the aneurysm.
  • FIG. 7 is an illustration of a vasoocclusive coil which has been introduced into an aneurysm preparatory to being deployed within the aneurysm.
  • FIG. 8 is an illustration of a spherical vasoocclusive coil formed with cable of the invention deployed within an aneurysm.
  • FIG. 9 is an alternate in a preferred embodiment of the invention including a plurality of radiopaque strands within the cable.
  • FIG. 10 is an alternate preferred embodiment incorporating a therapeutic member within the radiopaque cable of the invention.
  • FIG. 11 is an alternate preferred embodiment of the present invention wherein strands of the cable are arranged within an exterior binding consisting of multiple straps about the cable.
  • FIG. 12 is a perspective view of the embodiment of FIG. 11.
  • FIG. 13 is an alternative embodiment to the embodiment of FIG. 12 wherein the external binding of the cable represents a sheath wound about the cable.
  • FIGS. 14 a and 14 b are perspectives of alternative embodiments of the embodiment of FIG. 13.
  • FIG. 15 is a cross-section of an alternative embodiment in which a plurality of multi-strand cables are included within an external sheath surrounding the cable.
  • FIG. 16 is a perspective view of the embodiment of FIG. 14.
  • FIG. 17 is a plan view of a beaded radiopaque strand according to another preferred embodiment of the invention.
  • FIG. 18 is a sectional view of the beaded radiopaque strand of FIG. 17 inserted in a shape memory coil.
  • FIG. 19 is a plan view of an alternate preferred embodiment of a radiopaque strand with intermittent spaced apart coils.
  • FIG. 20 is a plan view of an alternate preferred embodiment of the radiopaque strand having spaced apart enlarged radiopaque portions.
  • FIG. 21 is a schematic diagram of a preferred three dimensional radiating coil configuration of a primary wind polyhedral occlusion device according to the principles of the invention.
  • FIG. 22 is a schematic diagram of an alternate preferred embodiment of a primary wind polyhedral occlusive device according to the principles of the invention.
  • FIG. 23 is a perspective view of a mandrel for forming the polyhedral occlusive device of FIG. 22.
  • FIG. 24 is a schematic diagram of an alternate preferred embodiment of a secondary wind polyhedral occlusive device according to the principles of the invention.
  • FIG. 25 is a perspective view of another preferred alternate embodiment of a helical vasoocclusive coil according to the principles of the invention, with a therapeutic fiber woven around adjacent loops of the coil.
  • FIG. 26 is a perspective view of another preferred alternate embodiment of a helical vasoocclusive coil according to the principles of the invention, with a plurality of therapeutic fibers woven around adjacent loops of the coil.
  • FIG. 27 is a perspective view of another preferred alternate embodiment of a helical multi-stranded vasoocclusive coil according to the principles of the invention, with a therapeutic fiber woven through strands of adjacent loops of a multi-stranded coil.
  • FIG. 28 is a perspective view of another preferred alternate embodiment of a helical multi-stranded vasoocclusive coil according to the principles of the invention, with a plurality of therapeutic fibers woven through strands of adjacent loops of a multi-stranded coil.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • While nickel-titanium alloys are useful in forming super-elastic or shape memory interventional devices, micro-coils formed of very small diameter wires of nickel-titanium alloy material for treatment of areas of the small diameter vasculature such as an artery or vein in the brain, for treatment of aneurysms and the like, for example, can have relatively low yield strengths and are somewhat subject to kinking, even if made of super-elastic alloy. This can create problems if the coil is to be withdrawn after being emplaced by the doctor, as for instance, if the device is too small to effectively fill the cavity to be treated. Furthermore, even solid wires of a size suitable for use in interventional devices are not very radiopaque.
  • As is illustrated in the drawings, which are provided for the purposes of illustration and not by way of limitation, the invention is embodied in a multi-stranded micro-cable formed of a plurality of flexible strands of a resilient material with the cable including at least one radiopaque strand. In a presently preferred embodiment of the invention illustrated in FIG. 1, the multi-stranded micro-cable 10 is approximately from 0.0015 to 0.009 inches in diameter, and comprises a plurality of flexible strands 12 of nickel-titanium alloy, with at least one centrally, axially disposed radiopaque wire 14 which is approximately from 0.0005 to 0.003 inches in diameter. While the above stated diameters represent those presently known to be compatible with the invention, larger or smaller diameters may be useful for particular applications. The central radiopaque wire 14 can be formed of platinum or gold, for example, or other similar suitable radiopaque metals, in order to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery.
  • There are numerous benefits to the novel construction of the invention for use in interventional devices and the like. By using the stranded or micro-cable construction of the invention, a device made from the micro-cable becomes virtually kink resistant compared to the single strand wires now commonly used in micro-coils. The multi-strand cable construction of the invention allows the micro-wires of the cable to slip across each other and reinforce each other rather than break or take a set. Also, by incorporating a stranded radiopaque material such as platinum, tungsten or gold into the cable construction, the device is radiopaque in sizes much smaller than with other constructions. The micro-cable construction of the invention can be used to produce soft, kink resistant, radiopaque stents, guidewires, guidewire distal tips, and micro-coils.
  • FIG. 2 is a cross-section of the micro-cable of FIG. 1 at 2-2 illustrating one presently preferred arrangement of the strands within the cable. In this embodiment, the exterior strands 12 are formed of a resilient material chosen to provide the characteristics desired for a specific application in interventional therapies. In a presently preferred embodiment, this material is a nickel titanium super-elastic alloy which is heat treated such that the alloy is highly flexible at a temperature appropriate for introduction into the body via a catheter. By choosing such a material for micro-coils and the like, the devices formed from the micro-cable can be relatively easily placed into the appropriate body cavity and after placement, the device will take on a shape designed to optimize the therapeutic purposes desired for the device. As illustrated in FIG. 2, such a cable can have a central core 14 of a radiopaque material such as gold or platinum, thus dramatically enhancing the radiopacity of the cable. Even a solid super-elastic wire of the same diameter as the cable would have substantially less radiopacity than the cable of the invention with the central gold or platinum wire and the construction of the invention provides numerous other highly desirable characteristics. Among these characteristics is the relative flexibility and resistance to kinking of the cable compared to an equivalent single wire and substantially greater accommodation of the cable to bending, etc., with resultant lessening of trauma to the surrounding tissue and ease of placement in a small body cavity.
  • One advantageous application of the invention is to vasoocclusive devices formed of the micro-cable for insertion into aneurysms and other vascular defects for the purpose of occluding flow to the aneurysm. FIG. 3 illustrates a helically wound coil 16 of micro-cable 10 which is formed to fit within a micro-catheter for insertion into an area upon which a therapeutic procedure is to be performed. While a helical coil is illustrated, it will be appreciated that numerous other secondary shapes can be formed from the cable of the invention, as will be described further below. More specifically, as illustrated in FIG. 4, a three dimensional, essentially spherical, device 18 can be formed of the cable 10, (or even of a coil of the cable, if appropriate) at a temperature sufficient to heat treat the material and thereby create a memory of the desired shape. The device is then inserted into a catheter from which it may be deployed into an aneurysm or the like. The teachings of U.S. Pat. No. 5,645,558 describe the construction of such a device out of flexible wire and are incorporated by referenced herein. FIG. 5 illustrates a collapsed coil configuration 20 for a vasoocclusive device which also can be formed from the cable of the invention and is used for the purposes of insertion into aneurysms and other defects that have relatively large entry necks compared to their internal volume.
  • FIG. 6 is an illustration of a catheter 22 using a coil 16 as a vasoocclusive device made of the present invention and used for insertion into an aneurysm 24 projecting laterally from a blood vessel 26. The coil 16 is contained within the outer housing 28 of a micro-catheter that is used to house the coil prior to deployment. The end of the catheter housing 28 is introduced into the opening 30 of the aneurism 24 by use of a guide wire (note shown). Thereafter, the vasoocclusive coil 16, and a pusher 32 are introduced into the catheter to provide for insertion of the vasoocclusive device into the aneurysm. In a presently preferred embodiment, the coil 16 formed of the cable of the invention is retained to an optical fiber pusher 32 which is attached to the coil by a collar of shape memory plastic material 34 as described in co-pending application Ser. No. 08/986,004 the disclosure of which are incorporated herein by reference. As shown in FIG. 7, the coil is introduced into the aneurysm and is then pushed from the micro-catheter until it fills the cavity.
  • Those skilled in the art will recognize that it is sometimes the case that the vasoocclusive device must be withdrawn after it is fully or partly inserted into the aneurysm. In such a case, there is a danger that the coil will be stretched beyond its elastic range or kink, or otherwise deform and make withdrawal difficult. Those skilled in the art will also recognize that it is sometimes advantageous to form vasoocclusive devices of secondary shapes which are based upon a basic configuration of a coil or the like. The present invention includes such applications within the scope of the invention. However, when vasoocclusive devices made of even super-elastic material are used, it is sometimes the case that the devices will be stretched or kinked when withdrawal is attempted. The cable of the present invention substantially reduces the probability that kinking or stretching beyond yield will occur in a given instance, while at the same time providing radiopacity not available with other constructions. Thus, the present invention represents an important forward step in the technology of interventional therapy.
  • In one presently preferred embodiment, the shape memory collar 34 is heated to a temperature which allows it to be shrunk onto coil 16. The collar is attached to optical fiber pusher 32 by an adhesive 36 which retains high strength at temperatures beyond the shape memory material transition point. After insertion, and when the operator is satisfied that the device is properly deployed, light energy from a source of coherent light is introduced into the proximal end of the optical fiber (not shown) and propagated in the distal end 38 of the fiber to cause the shape memory material collar 34 to return to its previous shape and release coil 16. Those skilled in the art will recognize that the invention can also be used with a variety of other placement catheter systems, and it is not intended that the invention be limited to the placement concepts illustrated by way of example.
  • Those skilled in the art will recognize that a number of shaped devices may be introduced into an area to be treated depending upon its geometry and the number of devices to be inserted. FIG. 8 illustrates an essentially spherical device 18 which has been deployed into such an aneurysm but it will commonly be found that a device such as that shown would then be supplemented by a further coiled device inserted within the space inside the spherical device to completely occlude flow from the artery to the aneurysm.
  • While one presently preferred implementation of the micro-cable of the invention has been illustrated, those skilled in the art will appreciate that other variations of the invention may have advantages for certain purposes. FIG. 9 is an example of one such construction 40 in which radiopacity is more desirable than in other forms and for that reason a number of radiopaque strands 42, in this illustration four in number, are formed into the cable along with three resilient material strands 44. It will also be appreciated that a larger or smaller number of strands may be incorporated into a given cable and the cables may be formed of multiple cables in order to provide desired bending and strength characteristics. It will also be appreciated by those skilled in the art that the invention is adaptable to the use of a variety of materials which by themselves would not have been easily adaptable to micro devices for interventional therapies. For instance, materials such as copper are useful for intrauterine devices and the like, but copper wire, even when heavily alloyed, has certain limitations for use in such devices. By use of the present invention, composite cables incorporating one or more strands of a desired material can be configured with other strands providing strength, flexibility, shape memory, super-elasticity, radiopacity or the like for previously unavailable characteristics in micro devices.
  • The invention is also adaptable to numerous other purposes. FIG. 10 illustrates a cross-section of a further preferred embodiment in which radiopaque strands 42 and resilient strands 44 form a portion of the cable and a therapeutic agent 48 is contained in one of the strands. Such a therapeutic agent can include human growth hormone, hydrogels, or a variety of other agents which will serve to provide desired therapeutic capabilities when placed within a specific area of the body being treated by use of the micro-catheter. Depending upon the application of the therapeutic agent, its method of action and the delay, if any, in the time after placement in which the therapeutic action is desired, the agent strand may be placed in any of a variety of positions with the cable, from core wire outward. Also, it may be desirable to coat one or more strands with a therapeutic material for certain purposes. Such constructions are contemplated within the scope of the invention.
  • It is also contemplated within the scope of the invention that one or more of the strands of the micro-cable is longer than the others, and perhaps intermittently terminated, to thereby produce a micro-cable in which the therapeutic strands extend to a greater diameter than the other strands to thus increase the therapeutic effect of the therapeutic stand. Such a construction is particularly advantageous if increased thrombogenicity is desired, while maintaining structural continuity and radiopacity for the micro-cable.
  • FIG. 11 illustrates a cross-section of an additional presently preferred embodiment of the invention in which the strands 12, 14 of the micro-cable 10 are bundled and banded at intervals by bands 50 to produce a composite banded cable 52 in order to provide increased flexibility without unraveling or dislocation of the strands in the cable. FIG. 12 is a perspective view of the banded cable 50 of this embodiment. While the illustrated configuration shows the strands being laid parallel within the cable, it is also possible in this construction to include both twisted cables as the primary cables 10 within the outer bands 50 to form the composite cable 52. This configuration can use one or more longitudinal strands 14 which are radiopaque, thus providing a continuous indication of radiopacity within the cable. As a further alternative embodiment, it is possible for the longitudinal cable 52 to be formed of a single inner cable 10 with bands 50.
  • FIG. 13 illustrates a further embodiment of the invention in which longitudinal strands of cables are contained within a wound cover 56 for the purposes of providing a composite guide wire or the like 58 having improved torqueability. Such a construction has particular advantages for guidewire designs having improved radiopacity in very small diameters. It will be appreciated that in this configuration, as well as the other longitudinally arranged multi-stranded cables, the number of strands and the degree to which they extend along the cable within the sheath is a variable which can be used to provide increased stiffness, pushability and torqueability in some sections with greater flexibility in others. Additionally, composite cables according to the invention can incorporate additional elements normally not available in solid guide wires, such as optical, thermal or ultrasound imaging elements, therapeutic agent delivery catheters, and can take advantage of materials which are not readily adaptable to prior art catheter or guide wire designs incorporating a primary wire structured element. FIGS. 14 a and 14 b illustrate a further variable available because of the invention; the exterior wrapped cover 56 can be wound at greater or lesser intervals 60 along the outside to provide variations in the torqueability and stiffness of the composite cable. Also, the thickness and width of the wrapping cover 56, as well as its material composition along the composite guide wire 58, can offer further capabilities for customizing the design for various applications. These advantages can be combined with the benefits of shape memory or super-elastic alloys to create guidewires and other devices with heretofore unavailable capabilities.
  • FIG. 15 illustrates a cross-section of a micro-cable according to the invention which has at least one overall exterior sheath to contain the micro-cable. The micro-cable may be made of one or more multiple strand elements which may further include twisted or longitudinal strands within their construction. The sheath may also be used to control the torqueability characteristics of the cable and as discussed in co-pending application Ser. No. 08/986,004, the sheath may be multi-layered with different materials in order to provide a graduated bending and stiffness characteristic over the length of the cable.
  • Referring to FIGS. 17 to 20, in another presently preferred embodiment, a nickel titanium alloy coil, such as the multi-stranded micro-cable described above, can be made radiopaque by the insertion of a radiopaque strand having spaced apart enlarged radiopaque portions into the core of a primary and/or secondary wind. The radiopaque material preferably has a desired degree of stiffness so as not to compromise the desired degree of softness of the coil. The material may comprise a beaded core of platinum, gold, shape memory polymer having a glass transition temperature (Tg) below 25° C., polymer, hydrogel, and the like, or a flexible strand, rod, amorphous gel, fiber, and the like. The radiopaque strand can be used to enhance the radiopacity of the multi-stranded coil, as indicated above, as well as a pure nickel titanium alloy coil, which will advantageously not fray upon stretching, and is stretch resistant. With such an inner radiopaque strand, the coil can also be made of other materials, such as a polyurethane shape memory polymer, for example.
  • In a presently preferred embodiment illustrated in FIGS. 17 and 18, the radiopaque strand 70 may comprise a plurality of beads 72 of radiopaque material, such as platinum, gold or tungsten, spaced apart and mounted, such as by soldering, welding, or adhesive bonding such as by cyanoacrylate adhesive, on a core strand 74 of material that can be platinum, gold or tungsten, or a shape memory polymer having a glass transition temperature (Tg) below 25° C. The beaded radiopaque strand can form the central core of a multi-stranded micro-cable, and as is shown in FIG. 18, the beaded radiopaque strand 70 may form a core of a pure nickel titanium alloy coil 76 wound around the beaded radiopaque strand, and having a proximal stem 77 bonded to the coil by soldering, welding, adhesive or the like, that can also be formed as a radiopaque marker, of such materials as platinum, gold or tungsten, for example. In a preferred aspect, one or more beads, such as an end bead 78, may optionally be bonded to a segment 80 of the coil, such as by cyanoacrylate adhesive 81, for example.
  • In another presently preferred embodiment illustrated in FIG. 19, the radiopaque strand can comprise a radiopaque wire 82, such as platinum or gold, for example, intermittently wound with a plurality of spaced apart coils 84 of radiopaque material, such as platinum or gold, for example, to form an inner radiopaque core for a multi-stranded micro-cable, or in an alternate preferred embodiment, the intermittently wound radiopaque strand may form a core of a pure nickel titanium alloy coil wound around the intermittently wound radiopaque strand.
  • Referring to FIG. 20, in another presently preferred embodiment, the radiopaque strand can comprise a radiopaque wire 86, such as platinum or gold, for example, with intermittently spaced apart enlarged radiopaque portions 88, to form an inner radiopaque core for a multi-stranded micro-cable, or for a pure nickel titanium alloy coil wound around the radiopaque strand.
  • It will be appreciated that a three dimensional occlusive device adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, can be formed as described above, from at least one multi-stranded micro-cable having a plurality of flexible strands of a resilient material, with at least one radiopaque strand to provide a radiopaque marker for the device during vascular surgery. The occlusive device is configured to have a primary coil shape, as illustrated in FIG. 5, and an expanded secondary three dimensional coil configuration or shape, that can be generally helical, conical, or spherical shapes, such as the spherical shapes illustrated in FIGS. 4 and 8. A mandrel suitable for making such three dimensionally shaped occlusive devices can be formed of a refractory material, such as alumina or zirconia, for example. The mandrel typically has the general three dimensional shape that the occlusive device will be given, and can have a generally helical, conical, or spherical shape, or can have a unique shape designed to provide such a form to the occlusive device to fit a particular vascular structure to be treated. The mandrel forms a support for the winding and heat treatment of the micro-cable, plurality of microcables, or composite micro-cable occlusive device as described above, and ideally will not contaminate the occlusive device during heat treatment of the device. The surface of the mandrel preferably has a plurality of circumferential grooves for aligning the occlusive device as it is wound on the mandrel. The surface of the mandrel may also have one or more apertures for receiving one or more ends of the micro-cable, plurality of microcables, or composite micro-cable, to assist winding into the desired form.
  • The wound occlusive device is then heat treated at a suitable temperature and a sufficient period of time to impart the form to the shape memory material included in the device. While heat treatment at a temperature of about 1100° F. for approximately 4 hours or more is typically sufficient to impart the form to the occlusive device when the shape memory material is a nickel titanium super-elastic alloy, but when the occlusive device includes fibers or a therapeutic agent that can be affected by heat, the temperature utilized can be substantially lowered, and the duration of heat treatment adjusted accordingly, as will be appreciated by those skilled in the art. Alternatively, if the therapeutic agent is not amenable to elevated temperatures, it may be added after formation of the three dimensional shape. After the heat treatment, the occlusive device is removed from the mandrel, and cold worked into the desired collapsed primary configuration for placement into a catheter or cannula for use. It will be appreciated that those techniques can also be used for a variety of cables produced according to the invention, including those which use shape memory materials other than nickel-titanium alloys. When the occlusive device reaches its destination in the vasculature during vascular therapy, it assumes the secondary relaxed and expanded three dimensional shape imparted from the heat treatment on the mandrel.
  • In another presently preferred embodiment, a three dimensional, polyhedral occlusive device is provided, adapted to be inserted into a portion of a vasculature for occluding a portion of the vasculature, for use in interventional therapy and vascular surgery. The occlusive device can be formed as described above, from at least one multi-stranded micro-cable having a plurality of flexible strands of a resilient material, with at least one radiopaque strand to provide a radiopaque marker for the device during vascular surgery, with multiple coils, preferably four or more coils, centrally connected together at their inner ends, and in a presently preferred aspect, connected at their inner ends to a central coil body and radiating outward from the central coil body. When inserted with a vessel at a treatment site, such as within an aneurysm, the radiating coil arms of the occlusive device extend to fill the vessel in three dimensions, allowing the occlusive device to accommodate the shape of the vessel. In a preferred aspect, the radiating coils of the occlusive device can thus form a tetrahedral, pentahedral, hexahedral, or other polyhedral shape, symmetrical or unsymmetrical, and are preferably formed from conically shaped coil arms that have an expanding diameter as they radiate outward from the central coil body, with the radiating coil arms having soft larger diameter outer ends. The central coil body may be spherical or rounded, or may be correspondingly cubical, tetrahedral, pentahedral, or otherwise appropriately polyhedral. A typical aneurysm may have a diameter of approximately 10 mm., and the coil arms will also typically have an outer diameter of approximately 10 mm.
  • As is illustrated in FIG. 21, one presently preferred three dimensional radiating coil configuration 90 is a primary wind coil having a hexahedral configuration with six conically shaped coil arms 92 radiating from a central coil junction 94 in the three x, y and z axes of a three dimensional pattern of coordinates. Such a three dimensional radiating coil configuration can be formed by individually winding the radiating arms of the hexahedral configuration on conically shaped mandrel, and bonding the inner apical ends 96 of the coils together by welding, solder, adhesive such as cyanoacrylate, or the like. A central coil body 98 such as the spherical coil described above is also preferably similarly bonded to the inner ends of the coil arms.
  • Referring to FIG. 22, in another presently preferred embodiment, a three dimensional radiating hexahedral coil configuration 100 for the occlusive device is also a primary wind coil with six conically shaped coils or coil arms 102 radiating from a central coil ball or sphere 104 in the three x, y and z axes forming a three dimensional pattern of coordinates. The central ball may also alternatively have the shape of a cube, for example. The outer diameter of the coil arms typically can be approximately 10 mm., and the diameter of the central coil ball or sphere typically can be 3 mm. in diameter. The hexahedral coil can be formed by winding the central spherical coil about a mandrel as described above and then joining the six radiating conical coil arms at their inner apical ends 106 to the central spherical coil 108, as described above, such as by welding, solder, adhesive such as cyanoacrylate, or the like. Alternatively, the hexahedral coil configuration can be formed as a continuous primary wind of the coil by winding the central spherical coil, and forming the radiating arms by a double winding of the radiating conical coil arms, first up from the center and then back down, with each of the radiating conical coil arms being wound in turn about the central spherical at the appropriate location.
  • Referring to FIG. 23, such a hexahedral configuration with six conically shaped coils radiating from a common central coil ball or sphere can be formed by winding the coils about a mandrel 110 formed of a refractory material, such as alumina or zirconia, for example, and having inverted conical coil arms 112 radiating from a central body 114, such as a spherical, rounded, cubical, tetrahedral, pentahedral or otherwise polyhedral central body, for example. The mandrel forms a support for the winding and heat treatment of the three dimensional radiating hexahedral coil occlusive device as described above, and ideally will not contaminate the occlusive device during heat treatment of the device. The surface of the central body of the mandrel preferably has a plurality of circumferential grooves 116 for aligning the occlusive device as it is wound on the mandrel. The surface of the mandrel may also have one or more apertures 118 for receiving one or more ends of the micro-cable, plurality of microcables, or composite micro-cable forming the hexahedral occlusive device, to assist winding into the desired form.
  • In another configuration illustrated in FIG. 24, a another presently preferred alternate three dimensional radiating coil configuration 120 is a secondary wind coil of a primary wind coil, such as a helical wind, for example, the secondary wind coil having a hexahedral configuration with six conically shaped-coil arms 122 radiating from the common central coil 124, which is illustrated as having a cubical shape, in the three x, y and z axes of a three dimensional pattern of coordinates. The outer diameter of the coil arms typically can be approximately 10 mm., and the diameter of the central coil ball or sphere typically can be 3 mm. in diameter. The hexahedral secondary wind configuration can be formed by winding the primary helical wind coil about an appropriate mandrel, and then joining the six radiating conical coil arms at their inner apical ends 126 to the common central coil 128, as described above, such as by welding, solder, adhesive such as cyanoacrylate, or the like. Alternatively, the hexahedral coil configuration can be formed as a continuous primary wind of the coil by winding the central coil body, and forming the radiating arms by a double winding of the radiating conical coil arms, first up from the center and then back down, with each of the radiating conical coil arms being wound in turn about the central spherical at the appropriate location.
  • As is described above, the tetrahedral, pentahedral, hexahedral or other polyhedral wound occlusive device radiating from the common central coil is then preferably heat treated upon the mandrel at a suitable temperature and for a sufficient period of time to impart the relaxed form to the shape memory material forming the device. The occlusive device can then be cold worked into a shape suitable for delivery through a catheter to a desired treatment site, and when the occlusive device reaches its destination in the vasculature during vascular therapy, it assumes the relaxed and expanded three dimensional shape imparted from the heat treatment on the mandrel.
  • In another presently preferred embodiment illustrated in FIGS. 25 and 26, a helical microcoil 130 that can be formed of one or more flexible strands of nickel-titanium alloy, has one or more therapeutic fibers 136 advantageously woven about adjacent loops of the coil, used to enhance treatment of the site after placement of the device. The helical microcoil can also be formed to include one or more axially disposed radiopaque wires, as described above. Alternatively, the one or more therapeutic fibers can be woven about non-adjacent loops of the coil as well. The therapeutic fibers are preferably made of a material that will provide a timed release of a therapeutic agent, such as human growth hormone, collagen, a modified polymer with growth factor, genetic material for gene therapy, antigens or the like, that are intended to become active after placement. When multiple fibers are provided, as is shown in FIG. 26, different fibers can be provided in the same coil with different therapeutic agents to provide different therapies. The fibers are preferably woven into the coil by hand after the heat setting of the coil shape.
  • In another presently preferred embodiment illustrated in FIGS. 27 and 28, a helical microcoil 140 formed of a plurality of flexible strands 142 of nickel-titanium alloy, with at least one centrally, axially disposed radiopaque wire 144 as described above, has one or more therapeutic fibers 136 as described above, advantageously woven through the multiple strands of adjacent loops of the coil, to enhance treatment of the site after placement of the device. Alternatively, the one or more therapeutic fibers can be woven through the strands of non-adjacent loops of the coil as well. When multiple fibers are provided, as is shown in FIG. 28, the different fibers can be provided in the same coil with different therapeutic agents to provide different therapies. The one or more fibers are preferably woven through the strands of the multiply-stranded microcoil by hand during winding of the multiply-stranded microcoil.
  • It will be apparent from the foregoing that while particular forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.

Claims (147)

1. A multi-stranded micro-cable for use in interventional therapy and vascular surgery, comprising:
a plurality of flexible strands of a resilient material; said micro-cable including at least one radiopaque strand to provide a radiopaque marker.
2. The multi-stranded micro-cable of claim 1, wherein at least one radiopaque strand comprises an axially disposed radiopaque wire.
3. The multi-stranded micro-cable of claim 1 wherein at least one of said plurality of flexible strands of a resilient material are comprised of a super-elastic material.
4. The multi-stranded micro-cable of claim 3 wherein at least one of said super-elastic material comprises a nickel titanium alloy.
5. The multi-stranded micro-cable of claim 1 wherein at least one of said plurality of flexible strands of a resilient material are comprised of a shape memory material.
6. The multi-stranded micro-cable of claim 5 wherein said shape memory material comprises a nickel-titanium alloy.
7. The multi-stranded micro-cable of claim 5 wherein said shape memory material comprises a shape memory polymer.
8. The multi-stranded micro-cable of claim 1 wherein said plurality of flexible strands further comprise a central core wire, said plurality of flexible strands are twisted about said central core wire, and at least one of said twisted strands comprising a radiopaque strand.
9. The multi-stranded micro-cable of claim 1 wherein said plurality of flexible strands further comprises a plurality of flexible strands twisted about a central core wire, said central core wire being made of a radiopaque material.
10. The multi-stranded micro-cable of claim 1 wherein said radiopaque strand comprises a material selected from the group consisting of platinum, gold, and tungsten.
11. The multi-stranded micro-cable of claim 5 wherein said radiopaque strands comprise a plurality of strands of said micro-cable, at least one of said plurality of radiopaque strands arrayed in the outer twisted strands of said cable.
12. The multi-stranded micro-cable of claim 1, further comprising at least one strand of a therapeutic material.
13. The multi-stranded micro-cable of claim 12 wherein said strand of therapeutic material is selected from the group consisting of hydrogel and human growth hormone.
14. The multi-stranded micro-cable of claim 1, further comprising a sheath to constrain said strands of said micro-cable about a longitudinal axis.
15. The multi-stranded micro-cable of claim 14 wherein said sheath comprises a containment strand wound about said longitudinal strands.
16. The multi-stranded micro-cable of claim 14 further comprising an outer flexible sheath of low friction material.
17. The multi-stranded micro-cable of claim 16 wherein said outer sheath comprises a fluoropolymer.
18. The multi-stranded micro-cable of claim 14 wherein said sheath comprises a heat shrinkable plastic tube.
19. A multi-stranded micro-cable for use in interventional therapy and vascular surgery comprising:
a plurality of flexible strands made of a resilient material helically wound around a central core, said central core comprising an axially placed therapeutic substance.
20. The multi-stranded micro-cable of claim 19 wherein said therapeutic substance includes one or more of components from the group of hydro-gel, collagen, bio-absorbable polymers such as lactic acids/glycolic acids and capro lactam.
21. The multi-stranded micro-cable of claim 19 wherein said cable further comprises at least one of said strands of resilient material being a radiopaque strand to provide a radiopaque marker during a therapeutic procedure.
22. The multi-stranded micro-cable of claim 19 wherein at least one of said flexible strands of the wire made of resilient material further comprises a shaped memory or super-elastic material.
23. The multi-stranded micro-cable of claim 19 wherein said shaped memory or super-elastic material further comprises a nickel titanium alloy.
24. The multi-stranded micro-cable of claim 19 wherein said therapeutic material further comprises material to promote human cell growth.
25. The multi-stranded micro-cable of claim 19 wherein said therapeutic substance core is a fiber such as Dacron (polyester), polyglycolic acid, polylactic acid, fluoropolymers, nylons, polyaramid fiber kevlar or silk chosen for thrombogenicity.
26. The multi-stranded micro-cable of claim 19 further comprising replacing at least one strand in said outer wound strands with a strand of a therapeutic material.
27. The multi-stranded micro-cable of claim 14 wherein said sheath further comprises a plurality of heat shrink plastic covers placed to provide bending stiffness in said cable which varies with the position on said cable.
28. The multi-stranded micro-cable of claim 14 wherein said sheath further comprises a sheath which varies in cross section along its length to provide bending stiffness of said cable which varies with the position on said cable.
29. The multi-stranded micro-cable of claim 14 further comprising at least one longitudinal element for sensing a parameter.
30. The multi-stranded micro-cable of claim 14 further comprising at least one longitudinal element for providing a therapeutic effect at a location near the distal end of said cable.
31. The multi-stranded micro-cable of claim 29 wherein said sensing element comprises an optical fiber.
32. The multi-stranded micro-cable of claim 30 wherein said therapeutic element comprises means to conduct energy.
33. The multi-stranded micro-cable of claim 32 wherein said means to conduct energy comprises an optical fiber to conduct light energy.
34. A device for use in interventional therapy and vascular surgery, adapted to be inserted into a portion of a vasculature, comprising:
at least one multi-stranded micro-cable having a collapsed primary coil configuration and an expanded secondary configuration with a three dimensional shape, each said multi-stranded micro-cable having a plurality of flexible strands of a resilient material and at least one radiopaque strand to provide a radiopaque marker of the deployed configuration of the device.
35. The device of claim 34, wherein said secondary three dimensional shape is selected from the group consisting of generally spherical, generally helical, and generally conical shapes.
36. The device of claim 34, wherein said plurality of strands are helically wound.
37. The device of claim 34, wherein said plurality of flexible strands are parallel longitudinal strands.
38. The device of claim 34, wherein at least one of said plurality of strands comprises a super-elastic material.
39. The device of claim 38, wherein said super-elastic material comprises a nickel titanium alloy.
40. The device of claim 34, wherein at least one of said strands comprises a shape memory material.
41. The device of claim 34, wherein said shape memory material comprises a nickel-titanium alloy.
42. The device of claim 41, wherein said shape memory nickel-titanium alloy is heat treated such that the alloy is highly flexible at a temperature appropriate for introduction into the body via a catheter, and after placement, the device will take on a shape designed to optimize the therapeutic purposes desired for the device.
43. The device of claim 34, wherein at least one of the strands comprises a therapeutic agent.
44. The device of claim 43 wherein said strand comprising a therapeutic agent is wound into said micro-cable so that at least a portion of said strand projects beyond the diameter of the other strands in said cable.
45. The device of claim 43, wherein said therapeutic agent comprises a fiber selected from the group consisting of Dacron (polyester), polyglycolic acid, polylactic acid, fluoropolymers, nylons, polyaramid fiber, keviar, silk chosen for thrombogenicity, human growth hormone, genetic material, antigens, hydrogel, collagen, and bio-absorbable polymers including lactic acids, glycolic acids, caprolactam and microcellular foams.
46. The device of claim 43, wherein said therapeutic agent comprises means to conduct energy.
47. The device of claim 46, wherein said means to conduct energy comprises an optical fiber to conduct light energy.
48. The device of claim 43, wherein said therapeutic agent is disposed axially in a central core
49. The device of claim 34, wherein said plurality of strands comprises a plurality of exterior strands surrounding at least one interior strand.
50. The device of claim 34, wherein said plurality of strands comprises a plurality of exterior strands surrounding a central core.
51. The device of claim 34, wherein said radiopaque strand comprises at least one centrally, axially disposed radiopaque wire.
52. The device of claim 34, wherein said radiopaque wire comprises a radiopaque material selected from the group consisting of platinum, tungsten, and gold.
53. The device of claim 34, wherein said micro-cable comprises a plurality of radiopaque strands.
54. The device of claim 34, wherein said strands of the micro-cable are bundled by at least one outer cover to produce a composite banded cable.
55. The device of claim 54, wherein said outer cover comprises a sheath to constrain said strands of said micro-cable about a longitudinal axis.
56. The device of claim 54, wherein said outer cover comprises an outer sheath of material to provide bending stiffness and constrain said longitudinal strands about said longitudinal axis.
57. The device of claim 55, wherein said sheath comprises a containment strand wound about said longitudinal strands.
58. The device of claim 55, wherein said sheath is made of low friction material.
59. The device of claim 55, wherein said sheath is made of a fluoropolymer.
60. The device of claim 55, wherein said sheath comprises a heat shrinkable plastic tube.
61. The device of claim 55, wherein said sheath comprises a plurality of heat shrink plastic covers placed to provide bending stiffness in said cable which varies with the position on said cable.
62. The device of claim 54, wherein said strands of the micro-cable are bundled by a plurality of bands disposed at intervals along said micro-cable to produce a composite banded cable.
63. The device of claim 61, wherein said strands are laid parallel within the composite banded cable.
64. The device of claim 55, wherein said strands are twisted within the composite banded cable.
65. The device of claim 56, wherein said outer cover is wound at varying intervals along the outside to provide variations in the torqueability and stiffness of the composite cable.
66. The device of claim 56, wherein the width of the outer cover is varied along the composite cable.
67. The device of claim 54, wherein said outer covering varies in cross section along its length to provide bending stiffness of said composite cable which varies along said composite cable.
68. The device of claim 54, wherein the number of strands and the degree to which they extend along said composite cable within the outer covering varies along said composite cable.
69. The device of claim 54, wherein said outer covering comprises a plurality of layers formed of different materials in order to provide a graduated bending and stiffness characteristic over the length of the cable.
70. The device of claim 54, wherein said composite microcable comprises a plurality of micro-cables disposed within said outer cover in order to provide desired bending and strength characteristics.
71. The device of claim 70, wherein said plurality of micro-cables are helically wound within said outer cover.
72. The device of claim 70, wherein said plurality of micro-cables extend parallel and longitudinally within said outer cover.
73. The device of claim 70, wherein said composite cable has a collapsed primary configuration and an expanded secondary configuration with a secondary shape.
74. The device of claim 73, wherein said secondary shape is three dimensional.
75. The device of claim 73, wherein said secondary shape is selected from the group consisting of spherical, helical, and conical shapes.
76. The device of claim 70, wherein said plurality of micro-cables are bundled by at least one outer cover to produce said composite banded cable.
77. The device of claim 76, wherein said plurality of micro-cables are banded at intervals by a plurality of bands.
78. The device of claim 34, further comprising at least one longitudinal element for sensing a parameter.
79. The device of claim 68, wherein said longitudinal element for sensing a parameter is selected from the group consisting of an optical imaging element, an optical fiber, a thermal imaging element, and an ultrasound imaging element.
80. A three dimensional composite device having a collapsed coil configuration with a primary shape and an expanded coil configuration with a secondary three dimensional shape for use in interventional therapy and vascular surgery, the device adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature, comprising:
a plurality of multi-stranded micro-cables having a collapsed coil configuration with a primary shape and an expanded coil configuration with a secondary three dimensional shape, each said multi-stranded micro-cable having a plurality of flexible strands of a resilient material, and at least one said strand being a radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery.
81. The three dimensional composite device of claim 80, said micro-cable further comprising at least one outer cover disposed over at least a portion of said plurality of multi-stranded micro-cables to produce a composite banded cable.
82. The three dimensional composite device of claim 81, wherein said secondary three dimensional shape is selected from the group consisting of generally spherical, generally helical, and generally conical shapes.
83. The three dimensional composite device of claim 81, wherein said plurality of strands are helically wound.
84. The three dimensional composite device of claim 81, wherein said plurality of flexible strands are parallel longitudinal strands.
85. The three dimensional composite device of claim 81, wherein at least one of said plurality of strands comprises a super-elastic material.
86. The three dimensional composite device of claim 81, wherein a plurality of said flexible strands are comprised of a super-elastic material.
87. The three dimensional composite device of claim 81, wherein said super-elastic material comprises a nickel titanium alloy.
88. The three dimensional composite device of claim 81, wherein at least one of said strands comprises a shape memory material.
89. The three dimensional composite device of claim 81, wherein a plurality of said flexible strands of a resilient material are comprised of a shape memory material.
90. The three dimensional composite device of claim 89, wherein said shape memory material comprises a nickel-titanium alloy.
91. The three dimensional composite device of claim 89, wherein said shape memory nickel-titanium alloy is heat treated such that the alloy is highly flexible at a temperature appropriate for introduction into the body via a catheter, and after placement, the device will take on a shape designed to optimize the therapeutic purposes desired for the device.
92. The three dimensional composite device of claim 89, wherein said shape memory material comprises a shape memory polymer.
93. The three dimensional composite device of claim 81, wherein at least one of the strands comprises a therapeutic agent selected from the group consisting of a fiber selected from the group consisting of Dacron (polyester), polyglycolic acid, polylactic acid, fluoropolymers, nylons, polyaramid fiber kevlar and silk chosen for thrombogenicity, human growth hormone, genetic material, antigens and hydrogels.
94. The three dimensional composite device of claim 93, wherein at least a portion of said strand of therapeutic agent projects beyond the diameter of the remaining strands on said cable.
95. The three dimensional composite device of claim 93, wherein said therapeutic agent comprises at least one component selected from the group consisting of hydrogel, collagen, and bio-absorbable polymers including lactic acids, glycolic acids and caprolactam.
96. The three dimensional composite device of claim 81, wherein said outer cover comprises a sheath to constrain said strands of said micro-cable about a longitudinal axis.
97. The three dimensional composite device of claim 81, wherein said outer cover comprises an outer sheath of material to provide bending stiffness and constrain said longitudinal strands about said longitudinal axis, said sheath being formed of a low friction material selected from the group consisting of a fluoropolymer and a heat shrinkable plastic tube.
98. The three dimensional composite device of claim 96, wherein said sheath comprises a containment strand wound about said longitudinal strands.
99. The three dimensional composite device of claim 96, wherein said sheath comprises a plurality of heat shrink plastic tubes placed to provide bending stiffness in said cable which varies with the position on said cable.
100. The three dimensional composite device of claim 81, wherein said strands of the micro-cable are bundled by a plurality of bands disposed at intervals along said micro-cable to produce a composite banded cable.
101. The three dimensional composite device of claim 100, wherein said strands are laid parallel within the composite banded cable.
102. The three dimensional composite device of claim 100, wherein said exterior wrapped cover is wound at varying intervals along the outside to provide variations in the torqueability and stiffness of the composite cable.
103. The three dimensional composite device of claim 100, wherein the width of the outer cover is varied along the composite cable.
104. The three dimensional composite device of claim 81, wherein said outer covering varies in cross section along its length to provide bending stiffness of said composite cable which varies along said composite cable.
105. The three dimensional composite device of claim 81, wherein the number of strands and the degree to which they extend along said composite cable within the outer covering varies along said composite cable.
106. The three dimensional composite device of claim 97, wherein outer covering comprises a plurality of layers formed of different materials in order to provide a graduated bending and stiffness characteristic over the length of the cable.
107. A device for use in interventional therapy and vascular surgery, adapted to be inserted into a portion of a vasculature, comprising:
a shape memory coil having an outer coil portion and an inner core portion, said shape memory coil having a collapsed primary coil configuration and an expanded secondary configuration with a three dimensional shape; and
a radiopaque strand extending through the core of the shape memory coil to provide a radiopaque marker of the deployed configuration of the device.
108. The device of claim 107, wherein said shape memory coil comprises a multi-stranded coil having a plurality of flexible strands of a resilient material.
109. The device of claim 107, wherein said shape memory coil comprises a single stranded coil.
110. The device of claim 109, wherein said single stranded coil comprises a nickel titanium alloy.
111. The device of claim 109, wherein said single stranded coil comprises a shape memory polymer.
112. The device of claim 107, wherein said radiopaque strand comprises a core strand having a plurality of intermittently spaced apart enlarged portions.
113. The device of claim 112, wherein said enlarged portions comprise a radiopaque material selected from the group consisting of platinum and gold.
114. The device of claim 112, wherein said enlarged portions comprise a plurality of beads of radiopaque material spaced apart and mounted on a core strand of material.
115. The device of claim 114, wherein said beads comprise a radiopaque material selected from the group consisting of platinum, gold and tungsten.
116. The device of claim 114, wherein at least one of said plurality of beads is bonded to a segment of the shape memory coil.
117. The device of claim 114, wherein an end bead is bonded to a segment of the shape memory coil.
118. The device of claim 112, wherein said enlarged portions comprise a plurality of coils intermittently wound about and spaced apart on said core strand.
119. The device of claim 118, wherein said core strand comprises a radiopaque material selected from the group consisting of platinum and gold.
120. The device of claim 118, wherein said spaced apart coils comprise a radiopaque material selected from the group consisting of platinum and gold.
121. The device of claim 112, wherein said core strand comprises a material selected from the group consisting of platinum, gold, a shape memory polymer having a glass transition temperature (Tg) below 25° C., a hydrogel, an amorphous gel, and a fiber.
122. An occlusive device for use in interventional therapy and vascular surgery, adapted to be inserted into a portion of a vasculature, said occlusive device comprising:
a plurality of coil arms formed of shape memory material having a collapsed primary coil configuration and a three dimensional, polyhedral expanded secondary configuration, said coil arms having inner and outer ends, said inner ends of said coil arms being connected together, and
a central coil body connected to said inner ends of said coil arms.
123. The occlusive device of claim 122, wherein said plurality of coil arms further comprises at least four coil arms.
124. The occlusive device of claim 122, wherein said plurality of coil arms comprise six radiating coil arms forming a hexahedral configuration.
125. The occlusive device of claim 122, wherein said plurality of coil arms are formed from conically shaped coils each having an inner apical end, and said inner apical ends being connected to said central body, said conically shaped coils having an expanding diameter as they radiate outward.
126. The occlusive device of claim 123, wherein said central body comprises a central three dimensional coil connecting said inner ends of said at least four coil arms together.
127. The occlusive device of claim 126, wherein said at least four coil arms comprise six radiating coil arms forming a hexahedral configuration.
128. The occlusive device of claim 126, wherein said plurality of coil arms are formed from conically shaped coils each having an inner apical end, and said inner apical ends being connected to said central body, said conically shaped coils having an expanding diameter as they radiate outward.
129. The occlusive device of claim 126, wherein said central three dimensional coil has a shape selected from the group consisting of spherical, rounded, and cubical shapes.
130. The occlusive device of claim 126, wherein said central three dimensional coil is tetrahedral.
131. The occlusive device of claim 130, wherein said at least four coil arms comprise four radiating coil arms forming a tetrahedral configuration.
132. The occlusive device of claim 127, wherein said central three dimensional coil is pentahedral.
133. The occlusive device of claim 132, wherein said at least four coil arms comprise five radiating coil arms forming a pentahedral configuration.
134. The occlusive device of claim 123, wherein said at least four coil arms comprise at least one multi-stranded micro-cable having a plurality of flexible strands of a resilient material, with at least one radiopaque strand to provide a radiopaque marker.
135. The occlusive device of claim 123, wherein said at least four coil arms comprise at least one secondary wind coil of a primary helical wind coil.
136. The occlusive device of claim 126, wherein said central three dimensional coil comprises a secondary wind coil of a primary helical wind coil.
137. A device for use in interventional therapy and vascular surgery, adapted to be inserted into a portion of a vasculature, comprising:
a coil having a collapsed primary coil configuration and an expanded secondary configuration with a three dimensional shape, said coil being formed from at least one flexible strand of a resilient material; and
at least one therapeutic fiber woven into the coil to enhance treatment of the site after placement of the device.
138. The device of claim 137 wherein said at least one flexible strand comprises a plurality of flexible strands of a resilient material, and at least one radiopaque strand to provide a radiopaque marker of the deployed configuration of the device.
139. The device of claim 137 wherein said at least one therapeutic fiber is woven about adjacent loops of the coil.
140. The device of claim 137 wherein said at least one therapeutic fiber is woven about non-adjacent loops of the coil.
141. The device of claim 138, wherein said at least one therapeutic fiber is woven through the multiple strands of adjacent loops of the coil.
142. The device of claim 138, wherein said at least one therapeutic fiber is woven through the multiple strands of non-adjacent loops of the coil.
143. The device of claim 137 wherein said at least one therapeutic fiber is made of a material that will provide a timed release of a therapeutic agent intended to become active after placement of the device.
144. The device of claim 143, wherein said therapeutic agent selected from the group consisting of human growth hormone, collagen, a modified polymer with growth factor, genetic material for gene therapy, and antigens.
145. The device of claim 143, wherein said at least one therapeutic fiber comprises a plurality of therapeutic fibers, with different fibers provided in the coil with different therapeutic agents to provide different therapies.
146. The device of claim 137 wherein said coil secondary three dimensional configuration is helical.
147. The device of claim 137 wherein said at least on flexible strand comprises a nickel-titanium alloy.
US11/435,373 1997-12-05 2006-05-16 Vasoocclusive device for treatment of aneurysms Abandoned US20070016233A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/435,373 US20070016233A1 (en) 1997-12-05 2006-05-16 Vasoocclusive device for treatment of aneurysms

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US98600497A 1997-12-05 1997-12-05
US09/019,841 US6159165A (en) 1997-12-05 1998-02-06 Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
PCT/US1998/025822 WO1999029260A2 (en) 1997-12-05 1998-12-04 Vasoocclusive device for treatment of aneurysms
WOPCT/US98/25822 1998-12-04
US10/628,767 US7326225B2 (en) 1997-12-05 2003-07-28 Vasoocclusive device for treatment of aneurysms
US11/435,373 US20070016233A1 (en) 1997-12-05 2006-05-16 Vasoocclusive device for treatment of aneurysms

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09/019,841 Continuation US6159165A (en) 1997-12-05 1998-02-06 Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US10/628,767 Continuation US7326225B2 (en) 1997-12-05 2003-07-28 Vasoocclusive device for treatment of aneurysms

Publications (1)

Publication Number Publication Date
US20070016233A1 true US20070016233A1 (en) 2007-01-18

Family

ID=26692670

Family Applications (4)

Application Number Title Priority Date Filing Date
US09/019,841 Expired - Lifetime US6159165A (en) 1997-12-05 1998-02-06 Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US09/762,539 Expired - Fee Related US6616617B1 (en) 1997-12-05 1998-12-04 Vasoocclusive device for treatment of aneurysms
US10/628,767 Expired - Fee Related US7326225B2 (en) 1997-12-05 2003-07-28 Vasoocclusive device for treatment of aneurysms
US11/435,373 Abandoned US20070016233A1 (en) 1997-12-05 2006-05-16 Vasoocclusive device for treatment of aneurysms

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US09/019,841 Expired - Lifetime US6159165A (en) 1997-12-05 1998-02-06 Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US09/762,539 Expired - Fee Related US6616617B1 (en) 1997-12-05 1998-12-04 Vasoocclusive device for treatment of aneurysms
US10/628,767 Expired - Fee Related US7326225B2 (en) 1997-12-05 2003-07-28 Vasoocclusive device for treatment of aneurysms

Country Status (6)

Country Link
US (4) US6159165A (en)
EP (3) EP1219246B1 (en)
JP (2) JP4303419B2 (en)
AU (1) AU1711799A (en)
DE (2) DE69822331T2 (en)
WO (1) WO1999029260A2 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040243168A1 (en) * 1997-12-05 2004-12-02 Ferrera David A. Vasoocclusive device for treatment of aneurysms
WO2009002412A2 (en) * 2007-06-22 2008-12-31 Neurovasx, Inc. Aneurysm filler detacher
US20090082800A1 (en) * 2007-09-21 2009-03-26 Insera Therapeutics Llc Distal Embolic Protection Devices With A Variable Thickness Microguidewire And Methods For Their Use
US20100023035A1 (en) * 2008-07-22 2010-01-28 Cook Incorporated Multi-stranded apparatus for treating a medical condition
WO2011084536A3 (en) * 2009-12-16 2011-11-03 Endoshape, Inc. Multi-fiber shape memory device
US8100881B2 (en) 2009-08-04 2012-01-24 Cook Medical Technologies Llc Flexible medical device for clot removal from small vessels
US20120158034A1 (en) * 2010-12-16 2012-06-21 Wilson Thomas S Expandable Implant and Implant System
US8366738B2 (en) 2007-11-09 2013-02-05 Micrus Endovascular Corporation Tethered coil for treatment of body lumens
WO2013130937A1 (en) * 2012-03-01 2013-09-06 Tufts University Endovascular silk-protein based embolization of blood vessels
US8728116B1 (en) 2013-07-29 2014-05-20 Insera Therapeutics, Inc. Slotted catheters
US8753371B1 (en) 2013-03-15 2014-06-17 Insera Therapeutics, Inc. Woven vascular treatment systems
US9179931B2 (en) 2013-03-15 2015-11-10 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy systems
US9314324B2 (en) 2013-03-15 2016-04-19 Insera Therapeutics, Inc. Vascular treatment devices and methods
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US9808252B2 (en) 2009-04-02 2017-11-07 Endoshape, Inc. Vascular occlusion devices
US9936892B1 (en) * 2009-05-04 2018-04-10 Cortex Manufacturing Inc. Systems and methods for providing a fiducial marker
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10201351B2 (en) 2011-09-30 2019-02-12 Endoshape, Inc. Continuous embolic coil and methods and devices for delivery of the same
US10390926B2 (en) 2013-07-29 2019-08-27 Insera Therapeutics, Inc. Aspiration devices and methods
US10561765B2 (en) 2015-07-27 2020-02-18 The Texas A&M University System Medical devices coated with shape memory polymer foams
US10603043B2 (en) 2012-01-17 2020-03-31 Endoshape, Inc. Occlusion device for a vascular or biological lumen
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10857012B2 (en) 2015-01-20 2020-12-08 Neurogami Medical, Inc. Vascular implant
US10925611B2 (en) 2015-01-20 2021-02-23 Neurogami Medical, Inc. Packaging for surgical implant
US11006940B2 (en) 2015-01-20 2021-05-18 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
US11219520B2 (en) 2017-03-14 2022-01-11 Shape Memory Medical, Inc. Shape memory polymer foams to seal space around valves
US11484319B2 (en) 2015-01-20 2022-11-01 Neurogami Medical, Inc. Delivery system for micrograft for treating intracranial aneurysms
US11504131B2 (en) 2017-07-31 2022-11-22 Kaneka Corporation In-vivo indwelling instrument, in-vivo indwelling instrument delivering system and method for producing in-vivo indwelling instrument
US11779452B2 (en) 2015-01-20 2023-10-10 Neurogami Medical, Inc. Vascular implant
US20230321325A1 (en) * 2018-03-12 2023-10-12 Fluid Biomed Inc. Bioabsorbable flow diverting scaffold and methods for its use

Families Citing this family (258)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638291B1 (en) * 1995-04-20 2003-10-28 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US6399886B1 (en) * 1997-05-02 2002-06-04 General Science & Technology Corp. Multifilament drawn radiopaque high elastic cables and methods of making the same
US7569066B2 (en) 1997-07-10 2009-08-04 Boston Scientific Scimed, Inc. Methods and devices for the treatment of aneurysms
US6511468B1 (en) 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
US6136015A (en) * 1998-08-25 2000-10-24 Micrus Corporation Vasoocclusive coil
US6168570B1 (en) * 1997-12-05 2001-01-02 Micrus Corporation Micro-strand cable with enhanced radiopacity
US20070093889A1 (en) * 1999-01-27 2007-04-26 Wu Benjamin M Non-Fragmenting Low Friction Bioactive Absorbable Coils for Brain Aneurysm Therapy
US6015424A (en) 1998-04-28 2000-01-18 Microvention, Inc. Apparatus and method for vascular embolization
US6113629A (en) * 1998-05-01 2000-09-05 Micrus Corporation Hydrogel for the therapeutic treatment of aneurysms
US6168615B1 (en) 1998-05-04 2001-01-02 Micrus Corporation Method and apparatus for occlusion and reinforcement of aneurysms
US6641593B1 (en) * 1998-06-03 2003-11-04 Coalescent Surgical, Inc. Tissue connector apparatus and methods
US6945980B2 (en) 1998-06-03 2005-09-20 Medtronic, Inc. Multiple loop tissue connector apparatus and methods
US6613059B2 (en) 1999-03-01 2003-09-02 Coalescent Surgical, Inc. Tissue connector apparatus and methods
US6478773B1 (en) 1998-12-21 2002-11-12 Micrus Corporation Apparatus for deployment of micro-coil using a catheter
US6835185B2 (en) 1998-12-21 2004-12-28 Micrus Corporation Intravascular device deployment mechanism incorporating mechanical detachment
US6371904B1 (en) 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US9669113B1 (en) 1998-12-24 2017-06-06 Devicor Medical Products, Inc. Device and method for safe location and marking of a biopsy cavity
US6356782B1 (en) 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6855123B2 (en) 2002-08-02 2005-02-15 Flow Cardia, Inc. Therapeutic ultrasound system
US8118822B2 (en) 1999-03-01 2012-02-21 Medtronic, Inc. Bridge clip tissue connector apparatus and methods
US6695859B1 (en) 1999-04-05 2004-02-24 Coalescent Surgical, Inc. Apparatus and methods for anastomosis
US6655218B1 (en) * 1999-05-28 2003-12-02 Fuji Jukogyo Kabushiki Kaisha Composite material and method of controlling damage thereto and damage sensor
EP1867300A3 (en) 1999-06-02 2008-02-27 Sethel Interventional, Inc. Intracorporeal occlusive device
US6280457B1 (en) * 1999-06-04 2001-08-28 Scimed Life Systems, Inc. Polymer covered vaso-occlusive devices and methods of producing such devices
US8529583B1 (en) 1999-09-03 2013-09-10 Medtronic, Inc. Surgical clip removal apparatus
US6926730B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Minimally invasive valve repair procedure and apparatus
US20050187564A1 (en) * 1999-12-23 2005-08-25 Swaminathan Jayaraman Occlusive coil manufacturing and delivery
US6790218B2 (en) 1999-12-23 2004-09-14 Swaminathan Jayaraman Occlusive coil manufacture and delivery
US7740637B2 (en) 2000-02-09 2010-06-22 Micrus Endovascular Corporation Apparatus and method for deployment of a therapeutic device using a catheter
WO2001066167A2 (en) * 2000-03-03 2001-09-13 Chuter Timothy A M Large vessel stents and occluders
US7220276B1 (en) 2000-03-06 2007-05-22 Surmodics, Inc. Endovascular graft coatings
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US6551332B1 (en) 2000-03-31 2003-04-22 Coalescent Surgical, Inc. Multiple bias surgical fastener
US6530934B1 (en) * 2000-06-06 2003-03-11 Sarcos Lc Embolic device composed of a linear sequence of miniature beads
US6740061B1 (en) 2000-07-28 2004-05-25 Ev3 Inc. Distal protection device
US6723108B1 (en) 2000-09-18 2004-04-20 Cordis Neurovascular, Inc Foam matrix embolization device
US8313504B2 (en) 2000-09-18 2012-11-20 Cordis Corporation Foam matrix embolization device
US6589265B1 (en) 2000-10-31 2003-07-08 Endovascular Technologies, Inc. Intrasaccular embolic device
US6743251B1 (en) * 2000-11-15 2004-06-01 Scimed Life Systems, Inc. Implantable devices with polymeric detachment junction
JP2006500115A (en) 2000-11-16 2006-01-05 マイクロスフエリツクス・エル・エル・シー Flexible and / or elastic seeds or strands for brachytherapy
US20020193813A1 (en) * 2001-05-04 2002-12-19 Concentric Medical Hydrogel filament vaso-occlusive device
US20030004568A1 (en) * 2001-05-04 2003-01-02 Concentric Medical Coated combination vaso-occlusive device
US20020193812A1 (en) * 2001-05-04 2002-12-19 Concentric Medical Hydrogel vaso-occlusive device
US6585754B2 (en) * 2001-05-29 2003-07-01 Scimed Life Systems, Inc. Absorbable implantable vaso-occlusive member
US6692510B2 (en) * 2001-06-14 2004-02-17 Cordis Neurovascular, Inc. Aneurysm embolization device and deployment system
US20030093111A1 (en) * 2001-10-26 2003-05-15 Concentric Medical Device for vaso-occlusion and interventional therapy
DE10155191A1 (en) * 2001-11-12 2003-05-22 Dendron Gmbh Medical implant
US20030195553A1 (en) 2002-04-12 2003-10-16 Scimed Life Systems, Inc. System and method for retaining vaso-occlusive devices within an aneurysm
US20040006354A1 (en) * 2002-07-02 2004-01-08 Dean Schaefer Coaxial stretch-resistant vaso-occlusive device
US20040006362A1 (en) * 2002-07-02 2004-01-08 Dean Schaefer Uniaxial multifilar vaso-occlusive device with high stretch resistance and low buckling strength
US7608058B2 (en) 2002-07-23 2009-10-27 Micrus Corporation Stretch resistant therapeutic device
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US8273100B2 (en) * 2002-07-31 2012-09-25 Microvention, Inc. Three element coaxial vaso-occlusive device
US20050171572A1 (en) * 2002-07-31 2005-08-04 Microvention, Inc. Multi-layer coaxial vaso-occlusive device
US9955994B2 (en) 2002-08-02 2018-05-01 Flowcardia, Inc. Ultrasound catheter having protective feature against breakage
US8227411B2 (en) 2002-08-20 2012-07-24 BioSurface Engineering Technologies, Incle FGF growth factor analogs
US7598224B2 (en) * 2002-08-20 2009-10-06 Biosurface Engineering Technologies, Inc. Dual chain synthetic heparin-binding growth factor analogs
US7335180B2 (en) 2003-11-24 2008-02-26 Flowcardia, Inc. Steerable ultrasound catheter
US7220233B2 (en) 2003-04-08 2007-05-22 Flowcardia, Inc. Ultrasound catheter devices and methods
US7137963B2 (en) 2002-08-26 2006-11-21 Flowcardia, Inc. Ultrasound catheter for disrupting blood vessel obstructions
US6942677B2 (en) 2003-02-26 2005-09-13 Flowcardia, Inc. Ultrasound catheter apparatus
US8066724B2 (en) 2002-09-12 2011-11-29 Medtronic, Inc. Anastomosis apparatus and methods
US8105345B2 (en) 2002-10-04 2012-01-31 Medtronic, Inc. Anastomosis apparatus and methods
US7993285B2 (en) * 2002-11-05 2011-08-09 Boston Scientific Scimed, Inc. Medical device having flexible distal tip
US20040115164A1 (en) * 2002-12-17 2004-06-17 Pierce Ryan K. Soft filament occlusive device delivery system
US20040193141A1 (en) * 2003-02-14 2004-09-30 Leopold Eric W. Intravascular flow modifier and reinforcement device and deployment system for same
CA2525792C (en) 2003-05-15 2015-10-13 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US7182769B2 (en) 2003-07-25 2007-02-27 Medtronic, Inc. Sealing clip, delivery systems, and methods
US7951091B2 (en) * 2003-07-31 2011-05-31 Tyco Healthcare Group Lp Guide wire with stranded tip
US20050043749A1 (en) 2003-08-22 2005-02-24 Coalescent Surgical, Inc. Eversion apparatus and methods
US7758510B2 (en) 2003-09-19 2010-07-20 Flowcardia, Inc. Connector for securing ultrasound catheter to transducer
US8394114B2 (en) 2003-09-26 2013-03-12 Medtronic, Inc. Surgical connection apparatus and methods
US20050090856A1 (en) * 2003-10-27 2005-04-28 Scimed Life Systems, Inc. Vasco-occlusive devices with bioactive elements
US7645292B2 (en) * 2003-10-27 2010-01-12 Boston Scientific Scimed, Inc. Vaso-occlusive devices with in-situ stiffening elements
US8014849B2 (en) * 2003-11-21 2011-09-06 Stryker Corporation Rotational markers
US7237313B2 (en) * 2003-12-05 2007-07-03 Boston Scientific Scimed, Inc. Elongated medical device for intracorporal use
US7879047B2 (en) 2003-12-10 2011-02-01 Medtronic, Inc. Surgical connection apparatus and methods
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
US20050165480A1 (en) * 2004-01-23 2005-07-28 Maybelle Jordan Endovascular treatment devices and methods
EP1718361B1 (en) * 2004-02-11 2015-06-17 Fort Wayne Metals Research Products Corporation Drawn strand filled tubing wire
US7420124B2 (en) * 2004-02-11 2008-09-02 Fort Wayne Metals Research Products Corp. Drawn strand filled tubing wire
JP4895826B2 (en) 2004-02-20 2012-03-14 バイオサーフェス エンジニアリング テクノロジーズ,インク. Bone morphogenetic protein-2 positive modulator
US20050192581A1 (en) * 2004-02-27 2005-09-01 Molz Fred J. Radiopaque, coaxial orthopedic tether design and method
US7485123B2 (en) * 2004-03-01 2009-02-03 Boston Scientific Scimed, Inc. Complex vaso-occlusive coils
US7488332B2 (en) * 2004-03-01 2009-02-10 Boston Scientific Scimed, Inc. Vaso-occlusive coils with non-overlapping sections
US20080228209A1 (en) * 2004-03-08 2008-09-18 Demello Richard M System and method for removal of material from a blood vessel using a small diameter catheter
WO2005087119A1 (en) * 2004-03-08 2005-09-22 Radius Medical Technologies, Inc. Small-diameter snare
US20070118165A1 (en) * 2004-03-08 2007-05-24 Demello Jonathan R System and method for removal of material from a blood vessel using a small diameter catheter
TWI434676B (en) 2004-03-19 2014-04-21 Merck Sharp & Dohme X-ray visible drug delivery device
US20050267510A1 (en) * 2004-05-26 2005-12-01 Nasser Razack Device for the endovascular treatment of intracranial aneurysms
WO2005123171A2 (en) * 2004-06-09 2005-12-29 Stout Medical Group Lp Three-dimensional coils for treatment of vascular aneurysms
US7540852B2 (en) 2004-08-26 2009-06-02 Flowcardia, Inc. Ultrasound catheter devices and methods
US8845676B2 (en) 2004-09-22 2014-09-30 Micro Therapeutics Micro-spiral implantation device
EP1793744B1 (en) 2004-09-22 2008-12-17 Dendron GmbH Medical implant
US8535345B2 (en) 2004-10-07 2013-09-17 DePuy Synthes Products, LLC Vasoocclusive coil with biplex windings to improve mechanical properties
WO2006055967A2 (en) * 2004-11-19 2006-05-26 Lumen Biomedical, Inc. Extendable device on an aspiration catheter
US8771294B2 (en) * 2004-11-26 2014-07-08 Biomerix Corporation Aneurysm treatment devices and methods
US20060116713A1 (en) * 2004-11-26 2006-06-01 Ivan Sepetka Aneurysm treatment devices and methods
US20060155324A1 (en) * 2005-01-12 2006-07-13 Porter Stephen C Vaso-occlusive devices with attached polymer structures
US8221343B2 (en) 2005-01-20 2012-07-17 Flowcardia, Inc. Vibrational catheter devices and methods for making same
US20110054511A1 (en) * 2005-01-26 2011-03-03 Micrus Endovascular Corporation Adding microscopic porosity to the surface of a microcoil to be used for medical implantation
US20060178696A1 (en) * 2005-02-04 2006-08-10 Porter Stephen C Macroporous materials for use in aneurysms
US20060217760A1 (en) * 2005-03-17 2006-09-28 Widomski David R Multi-strand septal occluder
EP1871306A4 (en) 2005-04-01 2012-03-21 Univ Colorado A graft fixation device and method
US20070001346A1 (en) * 2005-06-30 2007-01-04 Murty Vyakarnam Active embolization device
US20070185415A1 (en) * 2005-07-07 2007-08-09 Ressemann Thomas V Steerable guide wire with torsionally stable tip
US8267872B2 (en) * 2005-07-07 2012-09-18 St. Jude Medical, Cardiology Division, Inc. Steerable guide wire with torsionally stable tip
EP2345376B1 (en) * 2005-09-30 2012-07-04 Cook Medical Technologies LLC Coated vaso-occlusion device
US20070078480A1 (en) * 2005-10-04 2007-04-05 Boston Scientific Scimed, Inc. Self-expanding biodegradable or water-soluble vaso-occlusive devices
US10143456B2 (en) * 2005-10-07 2018-12-04 Alex Javois Left atrial appendage occlusion device
US8007509B2 (en) * 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8052714B2 (en) 2005-11-22 2011-11-08 Medtronic Vascular, Inc. Radiopaque fibers and filtration matrices
WO2007115208A2 (en) * 2006-03-30 2007-10-11 The Regents Of The University Of Colorado Shape memory polymer medical devices
US20070239194A1 (en) * 2006-04-05 2007-10-11 Boston Scientific Scimed, Inc. Vaso-occlusive devices having expandable fibers
CN101415449A (en) * 2006-04-06 2009-04-22 雷瓦医药公司 Embolism prosthesis for treating vas aneurysm
US8777979B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
KR20090008347A (en) 2006-04-17 2009-01-21 마이크로 테라퓨틱스 인코포레이티드 System and method for mechanically positioning intravascular implants
BRPI0711784B8 (en) 2006-06-15 2021-06-22 Microvention Inc embolization device constructed of expandable polymer and its method of preparation
CA2692240C (en) 2006-06-22 2018-03-13 Biosurface Engineering Technologies, Inc. Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis
US20080046092A1 (en) * 2006-08-17 2008-02-21 Richard Champion Davis Coil embolization device with stretch resistance fiber
US8034073B2 (en) * 2006-08-18 2011-10-11 Codman & Shurtleff, Inc. Stretch resistant embolic coil
US8715205B2 (en) 2006-08-25 2014-05-06 Cook Medical Tecnologies Llc Loop tip wire guide
EP2061546B1 (en) * 2006-09-07 2014-06-11 Cook Medical Technologies LLC Loop tip wire guide
WO2008041094A2 (en) 2006-10-06 2008-04-10 Lithotech Medical Ltd. Retrieval snare for extracting foreign objects from body cavities and method for manufacturing thereof
US7927348B2 (en) * 2006-10-10 2011-04-19 Codman & Shurtleff, Inc. Stretch resistant coil device
US8246643B2 (en) 2006-11-07 2012-08-21 Flowcardia, Inc. Ultrasound catheter having improved distal end
US20100192959A1 (en) * 2006-12-19 2010-08-05 The Regents Of The University Of Colorado, A Body Corporate Shape memory polymer-based transcervical device for permanent or temporary sterilization
JP5136747B2 (en) * 2007-02-01 2013-02-06 国立大学法人 名古屋工業大学 Bending degree detecting device and bending degree detecting method using the same
KR20100015521A (en) 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 An implant, a mandrel, and a method of forming an implant
US8328860B2 (en) 2007-03-13 2012-12-11 Covidien Lp Implant including a coil and a stretch-resistant member
EP2157937B1 (en) 2007-06-04 2017-03-22 Sequent Medical, Inc. Devices for treatment of vascular defects
US8361138B2 (en) * 2007-07-25 2013-01-29 Aga Medical Corporation Braided occlusion device having repeating expanded volume segments separated by articulation segments
US20090112251A1 (en) * 2007-07-25 2009-04-30 Aga Medical Corporation Braided occlusion device having repeating expanded volume segments separated by articulation segments
DE102007038446A1 (en) 2007-08-14 2009-02-19 pfm Produkte für die Medizin AG Embolisiereinrichtung
JP5580737B2 (en) 2007-08-17 2014-08-27 ミクラス エンドバスキュラー エルエルシー Twisted primary wind coil for vascular treatment, method for forming the same, and secondary wind coil
US8088140B2 (en) 2008-05-19 2012-01-03 Mindframe, Inc. Blood flow restorative and embolus removal methods
US9198687B2 (en) 2007-10-17 2015-12-01 Covidien Lp Acute stroke revascularization/recanalization systems processes and products thereby
US8545514B2 (en) 2008-04-11 2013-10-01 Covidien Lp Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby
US8585713B2 (en) 2007-10-17 2013-11-19 Covidien Lp Expandable tip assembly for thrombus management
US10123803B2 (en) 2007-10-17 2018-11-13 Covidien Lp Methods of managing neurovascular obstructions
US8926680B2 (en) 2007-11-12 2015-01-06 Covidien Lp Aneurysm neck bridging processes with revascularization systems methods and products thereby
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US9220522B2 (en) 2007-10-17 2015-12-29 Covidien Lp Embolus removal systems with baskets
US8372017B2 (en) * 2007-10-30 2013-02-12 General Electric Company Multi-stranded trackable guidewire
US8728141B2 (en) * 2007-12-11 2014-05-20 Cornell University Method and apparatus for sealing an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while maintaining substantially normal flow through the body lumen
CA2709379C (en) 2007-12-21 2016-08-16 Microvention, Inc. Hydrogel filaments for biomedical uses
WO2009086214A1 (en) 2007-12-21 2009-07-09 Microvention, Inc. A system and method of detecting implant detachment
US9242070B2 (en) 2007-12-21 2016-01-26 MicronVention, Inc. System and method for locating detachment zone of a detachable implant
ES2647310T3 (en) 2008-02-22 2017-12-20 Covidien Lp Device for flow restoration
US8177836B2 (en) 2008-03-10 2012-05-15 Medtronic, Inc. Apparatus and methods for minimally invasive valve repair
US20100076463A1 (en) * 2008-04-04 2010-03-25 Akshay Mavani Implantable fistula closure device
EP3970633A1 (en) 2008-04-21 2022-03-23 Covidien LP Braid-ball embolic devices and delivery systems
WO2009132141A1 (en) * 2008-04-22 2009-10-29 Coherex Medical, Inc. Device, system and method for aneurysm embolization
US9597087B2 (en) 2008-05-02 2017-03-21 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US8871900B2 (en) 2008-06-16 2014-10-28 University Of Rochester Fibroblast growth factor (FGF) analogs and uses thereof
CA2732507A1 (en) 2008-08-06 2010-02-11 Boston Scientific Scimed, Inc. Vaso-occlusive devices with textured surfaces
CA2756573A1 (en) 2008-08-19 2010-02-25 Micro Therapeutics, Inc. Detachable tip microcatheter
AU2009289474B2 (en) 2008-09-04 2015-09-03 Curaseal Inc. Inflatable devices for enteric fistula treatment
US20100094423A1 (en) * 2008-10-15 2010-04-15 Warsaw Orthopedic, Inc. Systems and methods for assessment of tension in an implant
US9427304B2 (en) * 2008-10-27 2016-08-30 St. Jude Medical, Cardiology Division, Inc. Multi-layer device with gap for treating a target site and associated method
US9119714B2 (en) * 2008-10-29 2015-09-01 The Regents Of The University Of Colorado, A Body Corporate Shape memory polymer prosthetic medical device
CA2750222C (en) 2009-01-22 2018-02-27 Cornell University Method and apparatus for restricting flow through the wall of a lumen
US8518060B2 (en) 2009-04-09 2013-08-27 Medtronic, Inc. Medical clip with radial tines, system and method of using same
US8668704B2 (en) 2009-04-24 2014-03-11 Medtronic, Inc. Medical clip with tines, system and method of using same
US10639396B2 (en) 2015-06-11 2020-05-05 Microvention, Inc. Polymers
US20120071911A1 (en) * 2009-05-20 2012-03-22 University Of Miami Spherical helix embolic coils for the treatment of cerebral aneurysms
US9014787B2 (en) * 2009-06-01 2015-04-21 Focal Therapeutics, Inc. Bioabsorbable target for diagnostic or therapeutic procedure
US8226566B2 (en) 2009-06-12 2012-07-24 Flowcardia, Inc. Device and method for vascular re-entry
US9220523B2 (en) 2009-09-14 2015-12-29 The Spectranetics Corporation Snaring systems and methods
JP2013505791A (en) * 2009-09-24 2013-02-21 マイクロベンション インコーポレイテッド Injectable hydrogel fiber for medical use
BR112012009287A2 (en) 2009-10-26 2017-06-06 Microvention Inc embolization device made of expandable polymer
US8353952B2 (en) 2010-04-07 2013-01-15 Medtronic Vascular, Inc. Stent with therapeutic substance
WO2011130081A1 (en) 2010-04-14 2011-10-20 Microvention, Inc. Implant delivery device
CN103249374B (en) 2010-07-02 2015-08-05 Pfm医疗股份公司 Left atrial appendage occlusion device
US20120022562A1 (en) * 2010-07-23 2012-01-26 Boston Scientific Scimed, Inc. Device to detect internal bleeding
EP2613735B1 (en) 2010-09-10 2018-05-09 Covidien LP Devices for the treatment of vascular defects
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US11298251B2 (en) 2010-11-17 2022-04-12 Abbott Cardiovascular Systems, Inc. Radiopaque intraluminal stents comprising cobalt-based alloys with primarily single-phase supersaturated tungsten content
JP5382953B2 (en) * 2011-01-28 2014-01-08 朝日インテック株式会社 Guide wire
US9427493B2 (en) 2011-03-07 2016-08-30 The Regents Of The University Of Colorado Shape memory polymer intraocular lenses
WO2012135859A2 (en) 2011-04-01 2012-10-04 Cornell University Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
US9504474B2 (en) 2011-05-23 2016-11-29 Stryker Corporation Vaso-occlusive devices with in-situ stiffening
WO2012174469A2 (en) 2011-06-16 2012-12-20 Curaseal Inc. Fistula treatment devices and related methods
EP2720623A4 (en) 2011-06-17 2015-04-22 Curaseal Inc Fistula treatment devices and methods
US9724494B2 (en) 2011-06-29 2017-08-08 Abbott Cardiovascular Systems, Inc. Guide wire device including a solderable linear elastic nickel-titanium distal end section and methods of preparation therefor
WO2013055703A1 (en) 2011-10-07 2013-04-18 Cornell University Method and apparatus for restricting flow through an opening in a body lumen while maintaining normal flow
JP2013094343A (en) * 2011-10-31 2013-05-20 Asahi Intecc Co Ltd Guide wire
WO2013078438A1 (en) * 2011-11-23 2013-05-30 Microvention, Inc. Embolic device with shaped wire
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
WO2013109269A1 (en) 2012-01-18 2013-07-25 Bard Peripheral Vascular, Inc. Vascular re-entry device
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US20130190799A1 (en) * 2012-01-24 2013-07-25 Boston Scientific Scimed, Inc. Occluding Device
WO2013119332A2 (en) 2012-02-09 2013-08-15 Stout Medical Group, L.P. Embolic device and methods of use
EP3572011B1 (en) * 2012-03-15 2022-06-22 Covidien LP Devices for the treatment of vascular defects
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9011884B2 (en) 2012-04-18 2015-04-21 Microvention, Inc. Embolic devices
US20130289389A1 (en) * 2012-04-26 2013-10-31 Focal Therapeutics Surgical implant for marking soft tissue
US10124087B2 (en) 2012-06-19 2018-11-13 Covidien Lp Detachable coupling for catheter
JP6293145B2 (en) 2012-08-02 2018-03-14 バード・ペリフェラル・バスキュラー・インコーポレーテッド Ultrasound catheter system
CN104918565B (en) 2012-11-13 2018-04-27 柯惠有限合伙公司 plugging device
US9011481B2 (en) * 2012-12-30 2015-04-21 Cook Medical Technologies Llc Vascular occlusion device having a jelly fish
US10660645B2 (en) 2013-03-15 2020-05-26 Embo Medical Limited Embolization systems
EP3756591A1 (en) 2013-03-15 2020-12-30 Embo Medical Limited Embolisation systems
US10675039B2 (en) 2013-03-15 2020-06-09 Embo Medical Limited Embolisation systems
US9681876B2 (en) 2013-07-31 2017-06-20 EMBA Medical Limited Methods and devices for endovascular embolization
US10010328B2 (en) 2013-07-31 2018-07-03 NeuVT Limited Endovascular occlusion device with hemodynamically enhanced sealing and anchoring
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
JP2015137428A (en) * 2014-01-20 2015-07-30 朝日インテック株式会社 Twisted wire and guide wire using the same
CA2940965A1 (en) 2014-02-27 2015-09-03 Incumedx, Inc. Embolic framing microcoils
JP6482766B2 (en) * 2014-03-19 2019-03-13 朝日インテック株式会社 Guide wire
US10124090B2 (en) 2014-04-03 2018-11-13 Terumo Corporation Embolic devices
US9629635B2 (en) 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
CN106456836B (en) 2014-04-29 2019-12-06 微仙美国有限公司 Polymers comprising active agents
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
CN106604696A (en) 2014-05-28 2017-04-26 斯瑞克欧洲控股有限责任公司 Vaso-occlusive devices and methods of use
ES2933054T3 (en) 2014-07-25 2023-01-31 Hologic Inc Implantable devices and techniques for oncoplastic surgery
WO2016014985A1 (en) 2014-07-25 2016-01-28 Incumedx, Inc. Covered embolic coils
US10792194B2 (en) 2014-08-26 2020-10-06 Curt G. Joa, Inc. Apparatus and methods for securing elastic to a carrier web
WO2016044188A1 (en) * 2014-09-15 2016-03-24 Jones Donald K Intralumenal occlusion devices having improved properties
US10576274B2 (en) 2014-12-30 2020-03-03 Spectranetics Llc Expanding coil coupling for lead extension and extraction
US9884184B2 (en) 2014-12-30 2018-02-06 The Spectranetics Corporation Wire hook coupling for lead extension and extraction
US10105533B2 (en) 2014-12-30 2018-10-23 The Spectranetics Corporation Multi-loop coupling for lead extension and extraction
US9731113B2 (en) 2014-12-30 2017-08-15 The Spectranetics Corporation Collapsing coil coupling for lead extension and extraction
US9375333B1 (en) 2015-03-06 2016-06-28 Covidien Lp Implantable device detachment systems and associated devices and methods
DE202015102060U1 (en) 2015-04-24 2016-07-27 Pfm Medical Ag A medical implant for occluding a defect opening, vessel, organ passage, or other opening in a human or animal body
US10159490B2 (en) 2015-05-08 2018-12-25 Stryker European Holdings I, Llc Vaso-occlusive devices
EP3329495B1 (en) 2015-07-28 2019-11-20 Illinois Tool Works Inc. Source wire assembly for radiographic applications
JP2019516425A (en) * 2016-05-13 2019-06-20 コヴィディエン リミテッド パートナーシップ Aneurysm treatment coil
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US20180140321A1 (en) 2016-11-23 2018-05-24 C. R. Bard, Inc. Catheter With Retractable Sheath And Methods Thereof
US11596726B2 (en) 2016-12-17 2023-03-07 C.R. Bard, Inc. Ultrasound devices for removing clots from catheters and related methods
US10758256B2 (en) 2016-12-22 2020-09-01 C. R. Bard, Inc. Ultrasonic endovascular catheter
US10582983B2 (en) 2017-02-06 2020-03-10 C. R. Bard, Inc. Ultrasonic endovascular catheter with a controllable sheath
JP6880523B2 (en) * 2017-03-22 2021-06-02 シャン、フア Utilization of shape memory alloy hypotubes and their vascular optical fiber guide wires
CN110891641B (en) * 2017-07-19 2022-06-07 朝日英达科株式会社 Guide wire
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11701268B2 (en) 2018-01-29 2023-07-18 Curt G. Joa, Inc. Apparatus and method of manufacturing an elastic composite structure for an absorbent sanitary product
US10905432B2 (en) 2018-08-22 2021-02-02 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US10912569B2 (en) 2018-08-22 2021-02-09 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
EP3840672A4 (en) * 2018-08-22 2022-05-04 Covidien LP Aneurysm treatment coils and associated systems and methods of use
US11259834B2 (en) 2018-10-30 2022-03-01 Biosense Webster (Israel) Ltd. Brain aneurysm tool with a wire deflection mechanism
US11129621B2 (en) 2018-12-17 2021-09-28 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11925538B2 (en) 2019-01-07 2024-03-12 Curt G. Joa, Inc. Apparatus and method of manufacturing an elastic composite structure for an absorbent sanitary product
US11317921B2 (en) 2019-03-15 2022-05-03 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
JP2022525316A (en) 2019-03-15 2022-05-12 シークエント メディカル インコーポレイテッド Filamentous devices for the treatment of angiopathy
EP3908208A4 (en) 2019-03-15 2022-10-19 Sequent Medical, Inc. Filamentary devices having a flexible joint for treatment of vascular defects
EP3886730B1 (en) * 2019-06-05 2023-11-15 Endoshape, Inc. Systems and devices for improved occlusion and delivery
US11173072B2 (en) 2019-09-05 2021-11-16 Curt G. Joa, Inc. Curved elastic with entrapment
US11883243B2 (en) 2019-10-31 2024-01-30 Orthopediatrics Corp. Assessment of tension between bone anchors
CN114630627A (en) 2019-11-04 2022-06-14 柯惠有限合伙公司 Devices, systems, and methods for treating intracranial aneurysms
WO2021199884A1 (en) * 2020-03-31 2021-10-07 テルモ株式会社 Embolization agent kit
US11134954B1 (en) * 2021-02-01 2021-10-05 Accumedical Beijing Ltd. Braided embolization apparatus
WO2023010056A2 (en) * 2021-07-27 2023-02-02 Wavegate Corporation Full-duplex epg system and electro-optical percutaneous lead

Citations (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1341052A (en) * 1916-06-15 1920-05-25 Francis G Gale Chain
US1667730A (en) * 1928-05-01 of chicago
US2078182A (en) * 1935-08-09 1937-04-20 Sirian Wire And Contact Compan Tungsten manufacture
US2549335A (en) * 1947-04-18 1951-04-17 Rahthus Max Ornamental chain
US3649224A (en) * 1968-04-18 1972-03-14 Sylvania Electric Prod Method of making nonsag filaments for electric lamps
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US4205680A (en) * 1978-01-13 1980-06-03 Work Wear Corporation, Inc. Radiopaque laparatomy sponge
US4257421A (en) * 1979-01-10 1981-03-24 Health Development Corporation Gastro-intestinal tube guide and stiffener
US4494531A (en) * 1982-12-06 1985-01-22 Cook, Incorporated Expandable blood clot filter
US4500658A (en) * 1983-06-06 1985-02-19 Austenal International, Inc. Radiopaque acrylic resin
US4502482A (en) * 1983-05-23 1985-03-05 Deluccia Victor C Endotracheal tube complex
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4638803A (en) * 1982-09-30 1987-01-27 Rand Robert W Medical apparatus for inducing scar tissue formation in a body
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4670286A (en) * 1983-09-20 1987-06-02 Allied Corporation Method of forming prosthetic devices
US4718907A (en) * 1985-06-20 1988-01-12 Atrium Medical Corporation Vascular prosthesis having fluorinated coating with varying F/C ratio
US4748986A (en) * 1985-11-26 1988-06-07 Advanced Cardiovascular Systems, Inc. Floppy guide wire with opaque tip
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4798606A (en) * 1985-02-26 1989-01-17 Corvita Corporation Reinforcing structure for cardiovascular graft
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4813925A (en) * 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US4832055A (en) * 1988-07-08 1989-05-23 Palestrant Aubrey M Mechanically locking blood clot filter
US4922924A (en) * 1989-04-27 1990-05-08 C. R. Bard, Inc. Catheter guidewire with varying radiopacity
US4932419A (en) * 1988-03-21 1990-06-12 Boston Scientific Corporation Multi-filar, cross-wound coil for medical devices
US4990155A (en) * 1989-05-19 1991-02-05 Wilkoff Howard M Surgical stent method and apparatus
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US4998916A (en) * 1989-01-09 1991-03-12 Hammerslag Julius G Steerable medical device
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US5026377A (en) * 1989-07-13 1991-06-25 American Medical Systems, Inc. Stent placement instrument and method
US5025799A (en) * 1987-05-13 1991-06-25 Wilson Bruce C Steerable memory alloy guide wires
US5092847A (en) * 1990-04-06 1992-03-03 Sherwood Medical Company Enteral feeding tube stylet
US5104404A (en) * 1989-10-02 1992-04-14 Medtronic, Inc. Articulated stent
US5108407A (en) * 1990-06-08 1992-04-28 Rush-Presbyterian St. Luke's Medical Center Method and apparatus for placement of an embolic coil
US5111829A (en) * 1989-06-28 1992-05-12 Boston Scientific Corporation Steerable highly elongated guidewire
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5176661A (en) * 1988-09-06 1993-01-05 Advanced Cardiovascular Systems, Inc. Composite vascular catheter
US5183085A (en) * 1991-09-27 1993-02-02 Hans Timmermans Method and apparatus for compressing a stent prior to insertion
US5184627A (en) * 1991-01-18 1993-02-09 Boston Scientific Corporation Infusion guidewire including proximal stiffening sheath
US5186992A (en) * 1990-03-12 1993-02-16 The Bentley-Harris Manufacturing Company Braided product and method of making same
US5197977A (en) * 1984-01-30 1993-03-30 Meadox Medicals, Inc. Drug delivery collagen-impregnated synthetic vascular graft
US5203772A (en) * 1989-01-09 1993-04-20 Pilot Cardiovascular Systems, Inc. Steerable medical device
US5211183A (en) * 1987-05-13 1993-05-18 Wilson Bruce C Steerable memory alloy guide wires
US5211658A (en) * 1991-11-05 1993-05-18 New England Deaconess Hospital Corporation Method and device for performing endovascular repair of aneurysms
US5213111A (en) * 1991-07-10 1993-05-25 Cook Incorporated Composite wire guide construction
US5217484A (en) * 1991-06-07 1993-06-08 Marks Michael P Retractable-wire catheter device and method
US5222969A (en) * 1992-03-16 1993-06-29 Rolando Gillis Intravascular stent for cardiovascular intervention
US5304194A (en) * 1991-10-02 1994-04-19 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5303714A (en) * 1990-11-09 1994-04-19 Boston Scientific Corporation Guidewire for crossing occlusions in blood vessels
US5312415A (en) * 1992-09-22 1994-05-17 Target Therapeutics, Inc. Assembly for placement of embolic coils using frictional placement
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5386828A (en) * 1991-12-23 1995-02-07 Sims Deltec, Inc. Guide wire apparatus with location sensing member
US5409015A (en) * 1993-05-11 1995-04-25 Target Therapeutics, Inc. Deformable tip super elastic guidewire
US5413597A (en) * 1990-12-29 1995-05-09 Krajicek; Milan Three-layer vascular prostheses
US5417708A (en) * 1994-03-09 1995-05-23 Cook Incorporated Intravascular treatment system and percutaneous release mechanism therefor
US5421338A (en) * 1988-03-21 1995-06-06 Boston Scientific Corporation Acoustic imaging catheter and the like
US5423849A (en) * 1993-01-15 1995-06-13 Target Therapeutics, Inc. Vasoocclusion device containing radiopaque fibers
US5423829A (en) * 1993-11-03 1995-06-13 Target Therapeutics, Inc. Electrolytically severable joint for endovascular embolic devices
US5486193A (en) * 1992-01-22 1996-01-23 C. R. Bard, Inc. System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder
US5514115A (en) * 1993-07-07 1996-05-07 Device For Vascular Intervention, Inc. Flexible housing for intracorporeal use
US5514128A (en) * 1992-08-18 1996-05-07 Spectranetics Corporation Fiber optic guide wire and support catheter therefor
US5514176A (en) * 1995-01-20 1996-05-07 Vance Products Inc. Pull apart coil stent
US5520194A (en) * 1993-12-07 1996-05-28 Asahi Intecc Co., Ltd. Guide wire for medical purpose and manufacturing process of coil thereof
US5522836A (en) * 1994-06-27 1996-06-04 Target Therapeutics, Inc. Electrolytically severable coil assembly with movable detachment point
US5523092A (en) * 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US5522819A (en) * 1994-05-12 1996-06-04 Target Therapeutics, Inc. Dual coil medical retrieval device
US5527354A (en) * 1991-06-28 1996-06-18 Cook Incorporated Stent formed of half-round wire
US5527338A (en) * 1992-09-02 1996-06-18 Board Of Regents, The University Of Texas System Intravascular device
US5601593A (en) * 1995-03-06 1997-02-11 Willy Rusch Ag Stent for placement in a body tube
US5603694A (en) * 1995-10-17 1997-02-18 Brown; Joe E. Infusion coil apparatus and method for delivering fluid-based agents intravascularly
US5607445A (en) * 1992-06-18 1997-03-04 American Biomed, Inc. Stent for supporting a blood vessel
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5618301A (en) * 1993-10-07 1997-04-08 Angiomed Ag Reducing stent, device with reducing stent and use of a reducing stent
US5624449A (en) * 1993-11-03 1997-04-29 Target Therapeutics Electrolytically severable joint for endovascular embolic devices
US5624461A (en) * 1995-06-06 1997-04-29 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
US5632772A (en) * 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5637113A (en) * 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
US5639277A (en) * 1995-04-28 1997-06-17 Target Therapeutics, Inc. Embolic coils with offset helical and twisted helical shapes
US5709707A (en) * 1995-10-30 1998-01-20 Children's Medical Center Corporation Self-centering umbrella-type septal closure device
US5718711A (en) * 1992-11-18 1998-02-17 Target Therapeutics, Inc. Ultrasoft embolism devices and process for using them
US5720764A (en) * 1994-06-11 1998-02-24 Naderlinger; Eduard Vena cava thrombus filter
US5725572A (en) * 1994-04-25 1998-03-10 Advanced Cardiovascular Systems, Inc. Radiopaque stent
US5733329A (en) * 1996-12-30 1998-03-31 Target Therapeutics, Inc. Vaso-occlusive coil with conical end
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US5733326A (en) * 1996-05-28 1998-03-31 Cordis Corporation Composite material endoprosthesis
US5741327A (en) * 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5749891A (en) * 1995-06-06 1998-05-12 Target Therapeutics, Inc. Multiple layered vaso-occlusive coils
US5762615A (en) * 1996-06-04 1998-06-09 Cordis Corporation Guideware having a distal tip with variable flexibility
US5766219A (en) * 1995-04-20 1998-06-16 Musc Foundation For Research Development Anatomically shaped vasoocclusive device and method for deploying same
US5876432A (en) * 1994-04-01 1999-03-02 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
US6013084A (en) * 1995-06-30 2000-01-11 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US6168592B1 (en) * 1996-07-26 2001-01-02 Target Therapeutics, Inc. Aneurysm closure device assembly
US6171326B1 (en) * 1998-08-27 2001-01-09 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US6340367B1 (en) * 1997-08-01 2002-01-22 Boston Scientific Scimed, Inc. Radiopaque markers and methods of using the same

Family Cites Families (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR592182A (en) 1924-03-24 1925-07-28 Urethral probe
US3194239A (en) * 1963-01-16 1965-07-13 Cornelius J P Sullivan Suture provided with radiopaque free metal
US3334629A (en) * 1964-11-09 1967-08-08 Bertram D Cohn Occlusive device for inferior vena cava
US3485234A (en) * 1966-04-13 1969-12-23 Cordis Corp Tubular products and method of making same
US3452740A (en) * 1966-05-31 1969-07-01 Us Catheter & Instr Corp Spring guide manipulator
US3452745A (en) 1966-09-23 1969-07-01 Seymour M Hutchinson Hand-operated pulsating cleaning device
US4161952A (en) * 1977-11-01 1979-07-24 Mieczyslaw Mirowski Wound wire catheter cardioverting electrode
GB2066839B (en) 1979-12-29 1984-03-14 Vysoka Skola Chem Tech Method of manufacture of perfumed detergents
DE3250058C2 (en) * 1981-09-16 1992-08-27 Medinvent S.A., Lausanne, Ch
US5055101A (en) * 1983-10-31 1991-10-08 Catheter Research, Inc. Variable shape guide apparatus
EP0183372A1 (en) 1984-10-19 1986-06-04 RAYCHEM CORPORATION (a Delaware corporation) Prosthetic stent
US5037377A (en) * 1984-11-28 1991-08-06 Medtronic, Inc. Means for improving biocompatibility of implants, particularly of vascular grafts
US4629458A (en) * 1985-02-26 1986-12-16 Cordis Corporation Reinforcing structure for cardiovascular graft
US4682607A (en) * 1985-12-02 1987-07-28 Vlv Associates Wire guide
EP0257091B1 (en) * 1986-02-24 1993-07-28 Robert E. Fischell An intravascular stent and percutaneous insertion system
SE453258B (en) * 1986-04-21 1988-01-25 Medinvent Sa ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING
SE459473B (en) 1987-02-13 1989-07-10 Stig Bengmark HOSE DEVICE, SPECIFICALLY BEFORE ADMINISTRATION OF FOODS DIRECTLY IN THE GAS
US5143085A (en) * 1987-05-13 1992-09-01 Wilson Bruce C Steerable memory alloy guide wires
US4850960A (en) * 1987-07-08 1989-07-25 Joseph Grayzel Diagonally tapered, bevelled tip introducing catheter and sheath and method for insertion
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
FR2632864B2 (en) * 1987-12-31 1990-10-19 Biomat Sarl ANTI-EMBOLIC ELASTIC FILTERING SYSTEM FOR CELLAR VEIN AND ASSEMBLY OF MEANS FOR ITS PLACEMENT
JP2561853B2 (en) * 1988-01-28 1996-12-11 株式会社ジェイ・エム・エス Shaped memory molded article and method of using the same
US4957479A (en) * 1988-10-17 1990-09-18 Vance Products Incorporated Indwelling ureteral stent placement apparatus
US5065769A (en) * 1988-11-23 1991-11-19 Boston Scientific Corporation Small diameter guidewires of multi-filar, cross-wound coils
US5037391A (en) * 1989-01-09 1991-08-06 Pilot Cardiovascular Systems, Inc. Steerable angioplasty device
US4856516A (en) * 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US5171273A (en) * 1989-01-13 1992-12-15 University Of Medicine And Dentistry Of New Jersey Synthetic collagen orthopaedic structures such as grafts, tendons and other structures
CH678393A5 (en) 1989-01-26 1991-09-13 Ulrich Prof Dr Med Sigwart
US5063935A (en) * 1989-04-27 1991-11-12 C. R. Bard, Inc. Catheter guidewire with varying radiopacity
CA2019063E (en) * 1989-06-29 2000-01-04 Brian L. Bates Hydrophilically coated flexible wire guide
US5152784A (en) * 1989-12-14 1992-10-06 Regents Of The University Of Minnesota Prosthetic devices coated with a polypeptide with type IV collagen activity
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5135516A (en) * 1989-12-15 1992-08-04 Boston Scientific Corporation Lubricious antithrombogenic catheters, guidewires and coatings
DE4102550A1 (en) 1990-02-02 1991-08-08 Stephan Prof Dr Bockenheimer Sealing blood vessel fistula - involves inserted sleeve with spiral support with turns bridged by impervious elastic material
ATE120377T1 (en) * 1990-02-08 1995-04-15 Howmedica INFLATABLE DILATATOR.
US5569245A (en) 1990-03-13 1996-10-29 The Regents Of The University Of California Detachable endovascular occlusion device activated by alternating electric current
US5354295A (en) 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5238004A (en) * 1990-04-10 1993-08-24 Boston Scientific Corporation High elongation linear elastic guidewire
US5071407A (en) * 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member
US5064435A (en) * 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5139243A (en) * 1990-07-30 1992-08-18 Peter J. Balsells Axial canted coil springs in sinusoidal form
US5041084A (en) * 1990-08-09 1991-08-20 Dlp, Inc. Single stage venous catheter
US5449372A (en) 1990-10-09 1995-09-12 Scimed Lifesystems, Inc. Temporary stent and methods for use and manufacture
JPH0683726B2 (en) * 1990-10-12 1994-10-26 日本精線株式会社 Guide wire for catheter
US5176625A (en) * 1990-10-25 1993-01-05 Brisson A Glen Stent for ureter
US5160341A (en) * 1990-11-08 1992-11-03 Advanced Surgical Intervention, Inc. Resorbable urethral stent and apparatus for its insertion
US5133731A (en) * 1990-11-09 1992-07-28 Catheter Research, Inc. Embolus supply system and method
US5174302A (en) * 1990-12-04 1992-12-29 Cordis Corporation Variable radiopacity guidewire with spaced highly radiopaque regions
US5341818A (en) 1992-12-22 1994-08-30 Advanced Cardiovascular Systems, Inc. Guidewire with superelastic distal portion
US5167233A (en) * 1991-01-07 1992-12-01 Endosonics Corporation Dilating and imaging apparatus
DE4104702C2 (en) * 1991-02-15 1996-01-18 Malte Neuss Implants for organ pathways in spiral form
US5228453A (en) * 1991-05-07 1993-07-20 Target Therapeutics, Inc. Catheter guide wire
US5241970A (en) * 1991-05-17 1993-09-07 Wilson-Cook Medical, Inc. Papillotome/sphincterotome procedures and a wire guide specially
CA2069052A1 (en) 1991-05-21 1992-11-22 L. Venkata Raman Superelastic formable guidewire
US5147370A (en) * 1991-06-12 1992-09-15 Mcnamara Thomas O Nitinol stent for hollow body conduits
US5141502A (en) * 1991-08-28 1992-08-25 Macaluso Jr Joseph N Ureteral stent
US5226911A (en) * 1991-10-02 1993-07-13 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5151105A (en) * 1991-10-07 1992-09-29 Kwan Gett Clifford Collapsible vessel sleeve implant
US5354309A (en) 1991-10-11 1994-10-11 Angiomed Ag Apparatus for widening a stenosis in a body cavity
US5256146A (en) * 1991-10-11 1993-10-26 W. D. Ensminger Vascular catheterization system with catheter anchoring feature
US5253653A (en) * 1991-10-31 1993-10-19 Boston Scientific Corp. Fluoroscopically viewable guidewire for catheters
US5246014A (en) * 1991-11-08 1993-09-21 Medtronic, Inc. Implantable lead system
US5234437A (en) * 1991-12-12 1993-08-10 Target Therapeutics, Inc. Detachable pusher-vasoocclusion coil assembly with threaded coupling
US5258042A (en) * 1991-12-16 1993-11-02 Henry Ford Health System Intravascular hydrogel implant
US5243996A (en) * 1992-01-03 1993-09-14 Cook, Incorporated Small-diameter superelastic wire guide
DE69332950T2 (en) * 1992-03-31 2004-05-13 Boston Scientific Corp., Natick BLOOD VESSEL FILTER
US5251640A (en) * 1992-03-31 1993-10-12 Cook, Incorporated Composite wire guide shaft
US5465732A (en) 1992-03-31 1995-11-14 Boston Scientific Corporation Fluoroscopically viewable multifilar calibrated guidewire and method of measuring occlusions with calibrated guidewires
US5259393A (en) * 1992-05-13 1993-11-09 Cordis Corporation Guidewire having controlled radiopacity tip
US5443478A (en) 1992-09-02 1995-08-22 Board Of Regents, The University Of Texas System Multi-element intravascular occlusion device
US5350397A (en) 1992-11-13 1994-09-27 Target Therapeutics, Inc. Axially detachable embolic coil assembly
US5250071A (en) * 1992-09-22 1993-10-05 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking clasps and method of use
US5356388A (en) 1992-09-22 1994-10-18 Target Therapeutics, Inc. Perfusion catheter system
FR2696097B1 (en) 1992-09-29 1994-11-04 Nivarox Sa Guide support for catheter formed in particular by a multi-strand rolled sheath.
JP2581148Y2 (en) * 1992-12-21 1998-09-21 株式会社パイオラックス Treatment device for tubular organs
ES2166370T3 (en) 1993-01-19 2002-04-16 Schneider Usa Inc IMPLANTABLE FILAMENT IN COMPOSITE MATERIAL.
US5706809A (en) * 1993-01-29 1998-01-13 Cardima, Inc. Method and system for using multiple intravascular sensing devices to detect electrical activity
US5645082A (en) 1993-01-29 1997-07-08 Cardima, Inc. Intravascular method and system for treating arrhythmia
US5336205A (en) 1993-02-25 1994-08-09 Target Therapeutics, Inc. Flow directed catheter
JP2586167Y2 (en) * 1993-04-20 1998-12-02 株式会社東海理化電機製作所 Guidewire having in-vivo indwelling separation structure
US5531715A (en) 1993-05-12 1996-07-02 Target Therapeutics, Inc. Lubricious catheters
US5462523A (en) 1993-05-18 1995-10-31 Target Therapeutics, Inc. Drug delivery system
IL105828A (en) 1993-05-28 1999-06-20 Medinol Ltd Medical stent
ES2120489T3 (en) 1993-06-02 1998-11-01 Schneider Europ Gmbh DEVICE TO RELEASE A SELF-EXPANSIVE ENDOPROTESIS.
CA2125258C (en) 1993-08-05 1998-12-22 Dinah B Quiachon Multicapsule intraluminal grafting system and method
US5439485A (en) 1993-09-24 1995-08-08 Ventritex, Inc. Flexible defibrillation electrode of improved construction
US5437282A (en) 1993-10-29 1995-08-01 Boston Scientific Corporation Drive shaft for acoustic imaging catheters and flexible catheters
AU686315B2 (en) 1994-02-07 1998-02-05 Kabushikikaisya Igaki Iryo Sekkei Stent device and stent supply system
US5429597A (en) 1994-03-01 1995-07-04 Boston Scientific Corporation Kink resistant balloon catheter and method for use
DE69534194T2 (en) 1994-03-03 2006-02-16 Boston Scientific Ltd., Barbados DEVICE FOR SEARCHING THE DIVISION IN A VASSOUCHCLUSION DEVICE
IL108832A (en) 1994-03-03 1999-12-31 Medinol Ltd Urological stent and deployment device therefor
US5441516A (en) 1994-03-03 1995-08-15 Scimed Lifesystems Inc. Temporary stent
US5549663A (en) 1994-03-09 1996-08-27 Cordis Corporation Endoprosthesis having graft member and exposed welded end junctions, method and procedure
WO1995025480A1 (en) * 1994-03-18 1995-09-28 Cook Incorporated Helical embolization coil
US5683411A (en) 1994-04-06 1997-11-04 William Cook Europe A/S Medical article for implantation into the vascular system of a patient
US5693085A (en) 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
US5540701A (en) 1994-05-20 1996-07-30 Hugh Sharkey Passive fixation anastomosis method and device
US5549624A (en) 1994-06-24 1996-08-27 Target Therapeutics, Inc. Fibered vasooclusion coils
US5460187A (en) 1994-07-01 1995-10-24 Boston Scientific Corp. Fluoroscopically viewable guidewire
US5690671A (en) 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US5814062A (en) 1994-12-22 1998-09-29 Target Therapeutics, Inc. Implant delivery assembly with expandable coupling/decoupling mechanism
DE69624525T2 (en) 1995-03-30 2003-03-20 Boston Scient Ltd System for implanting liquid spirals with a secondary structure
US5853418A (en) * 1995-06-30 1998-12-29 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
ATE197388T1 (en) * 1995-06-30 2000-11-11 Target Therapeutics Inc EXPANSION-RESISTANT VASO-OCCLUSIVE SPIRAL
US5582619A (en) 1995-06-30 1996-12-10 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils
US6090063A (en) * 1995-12-01 2000-07-18 C. R. Bard, Inc. Device, system and method for implantation of filaments and particles in the body
AU690862B2 (en) 1995-12-04 1998-04-30 Target Therapeutics, Inc. Fibered micro vaso-occlusive devices
US5658308A (en) * 1995-12-04 1997-08-19 Target Therapeutics, Inc. Bioactive occlusion coil
US5690643A (en) 1996-02-20 1997-11-25 Leocor, Incorporated Stent delivery system
US5649949A (en) 1996-03-14 1997-07-22 Target Therapeutics, Inc. Variable cross-section conical vasoocclusive coils
US5824042A (en) 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US5792154A (en) * 1996-04-10 1998-08-11 Target Therapeutics, Inc. Soft-ended fibered micro vaso-occlusive devices
WO1997042881A1 (en) * 1996-05-14 1997-11-20 PFM PRODUKTE FüR DIE MEDIZIN AKTIENGESELLSCHAFT Strengthened implant for bodily ducts
DE19704269A1 (en) * 1996-05-14 1997-11-20 Pfm Prod Fuer Die Med Ag Reinforced implant for organ pathways
US5669933A (en) 1996-07-17 1997-09-23 Nitinol Medical Technologies, Inc. Removable embolus blood clot filter
US5676697A (en) 1996-07-29 1997-10-14 Cardiovascular Dynamics, Inc. Two-piece, bifurcated intraluminal graft for repair of aneurysm
US5655548A (en) 1996-09-16 1997-08-12 Circulation, Inc. Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion
US5690667A (en) 1996-09-26 1997-11-25 Target Therapeutics Vasoocclusion coil having a polymer tip
US5824045A (en) 1996-10-21 1998-10-20 Inflow Dynamics Inc. Vascular and endoluminal stents
US5814064A (en) 1997-03-06 1998-09-29 Scimed Life Systems, Inc. Distal protection device
US6399886B1 (en) * 1997-05-02 2002-06-04 General Science & Technology Corp. Multifilament drawn radiopaque high elastic cables and methods of making the same
US5800525A (en) 1997-06-04 1998-09-01 Vascular Science, Inc. Blood filter
AU8772198A (en) * 1997-08-05 1999-03-08 Target Therapeutics, Inc. Detachable aneurysm neck bridge
US6136015A (en) * 1998-08-25 2000-10-24 Micrus Corporation Vasoocclusive coil
US6159165A (en) * 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US6093199A (en) * 1998-08-05 2000-07-25 Endovascular Technologies, Inc. Intra-luminal device for treatment of body cavities and lumens and method of use

Patent Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1667730A (en) * 1928-05-01 of chicago
US1341052A (en) * 1916-06-15 1920-05-25 Francis G Gale Chain
US2078182A (en) * 1935-08-09 1937-04-20 Sirian Wire And Contact Compan Tungsten manufacture
US2549335A (en) * 1947-04-18 1951-04-17 Rahthus Max Ornamental chain
US3649224A (en) * 1968-04-18 1972-03-14 Sylvania Electric Prod Method of making nonsag filaments for electric lamps
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US4205680A (en) * 1978-01-13 1980-06-03 Work Wear Corporation, Inc. Radiopaque laparatomy sponge
US4257421A (en) * 1979-01-10 1981-03-24 Health Development Corporation Gastro-intestinal tube guide and stiffener
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4655771B1 (en) * 1982-04-30 1996-09-10 Medinvent Ams Sa Prosthesis comprising an expansible or contractile tubular body
US4638803A (en) * 1982-09-30 1987-01-27 Rand Robert W Medical apparatus for inducing scar tissue formation in a body
US4494531A (en) * 1982-12-06 1985-01-22 Cook, Incorporated Expandable blood clot filter
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4502482A (en) * 1983-05-23 1985-03-05 Deluccia Victor C Endotracheal tube complex
US4500658A (en) * 1983-06-06 1985-02-19 Austenal International, Inc. Radiopaque acrylic resin
US4670286A (en) * 1983-09-20 1987-06-02 Allied Corporation Method of forming prosthetic devices
US5197977A (en) * 1984-01-30 1993-03-30 Meadox Medicals, Inc. Drug delivery collagen-impregnated synthetic vascular graft
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4798606A (en) * 1985-02-26 1989-01-17 Corvita Corporation Reinforcing structure for cardiovascular graft
US4718907A (en) * 1985-06-20 1988-01-12 Atrium Medical Corporation Vascular prosthesis having fluorinated coating with varying F/C ratio
US4748986A (en) * 1985-11-26 1988-06-07 Advanced Cardiovascular Systems, Inc. Floppy guide wire with opaque tip
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4813925A (en) * 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US5211183A (en) * 1987-05-13 1993-05-18 Wilson Bruce C Steerable memory alloy guide wires
US5025799A (en) * 1987-05-13 1991-06-25 Wilson Bruce C Steerable memory alloy guide wires
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US4932419A (en) * 1988-03-21 1990-06-12 Boston Scientific Corporation Multi-filar, cross-wound coil for medical devices
US5421338A (en) * 1988-03-21 1995-06-06 Boston Scientific Corporation Acoustic imaging catheter and the like
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US4832055A (en) * 1988-07-08 1989-05-23 Palestrant Aubrey M Mechanically locking blood clot filter
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US5176661A (en) * 1988-09-06 1993-01-05 Advanced Cardiovascular Systems, Inc. Composite vascular catheter
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5203772A (en) * 1989-01-09 1993-04-20 Pilot Cardiovascular Systems, Inc. Steerable medical device
US4998916A (en) * 1989-01-09 1991-03-12 Hammerslag Julius G Steerable medical device
US4922924A (en) * 1989-04-27 1990-05-08 C. R. Bard, Inc. Catheter guidewire with varying radiopacity
US4990155A (en) * 1989-05-19 1991-02-05 Wilkoff Howard M Surgical stent method and apparatus
US5111829A (en) * 1989-06-28 1992-05-12 Boston Scientific Corporation Steerable highly elongated guidewire
US5026377A (en) * 1989-07-13 1991-06-25 American Medical Systems, Inc. Stent placement instrument and method
US5104404A (en) * 1989-10-02 1992-04-14 Medtronic, Inc. Articulated stent
US5186992A (en) * 1990-03-12 1993-02-16 The Bentley-Harris Manufacturing Company Braided product and method of making same
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5092847A (en) * 1990-04-06 1992-03-03 Sherwood Medical Company Enteral feeding tube stylet
US5108407A (en) * 1990-06-08 1992-04-28 Rush-Presbyterian St. Luke's Medical Center Method and apparatus for placement of an embolic coil
US5303714A (en) * 1990-11-09 1994-04-19 Boston Scientific Corporation Guidewire for crossing occlusions in blood vessels
US5413597A (en) * 1990-12-29 1995-05-09 Krajicek; Milan Three-layer vascular prostheses
US5184627A (en) * 1991-01-18 1993-02-09 Boston Scientific Corporation Infusion guidewire including proximal stiffening sheath
US5217484A (en) * 1991-06-07 1993-06-08 Marks Michael P Retractable-wire catheter device and method
US5527354A (en) * 1991-06-28 1996-06-18 Cook Incorporated Stent formed of half-round wire
US5213111A (en) * 1991-07-10 1993-05-25 Cook Incorporated Composite wire guide construction
US5183085A (en) * 1991-09-27 1993-02-02 Hans Timmermans Method and apparatus for compressing a stent prior to insertion
US5304194A (en) * 1991-10-02 1994-04-19 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5211658A (en) * 1991-11-05 1993-05-18 New England Deaconess Hospital Corporation Method and device for performing endovascular repair of aneurysms
US5386828A (en) * 1991-12-23 1995-02-07 Sims Deltec, Inc. Guide wire apparatus with location sensing member
US5486193A (en) * 1992-01-22 1996-01-23 C. R. Bard, Inc. System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder
US5222969A (en) * 1992-03-16 1993-06-29 Rolando Gillis Intravascular stent for cardiovascular intervention
US5607445A (en) * 1992-06-18 1997-03-04 American Biomed, Inc. Stent for supporting a blood vessel
US5514128A (en) * 1992-08-18 1996-05-07 Spectranetics Corporation Fiber optic guide wire and support catheter therefor
US5527338A (en) * 1992-09-02 1996-06-18 Board Of Regents, The University Of Texas System Intravascular device
US5312415A (en) * 1992-09-22 1994-05-17 Target Therapeutics, Inc. Assembly for placement of embolic coils using frictional placement
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5522822A (en) * 1992-10-26 1996-06-04 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5718711A (en) * 1992-11-18 1998-02-17 Target Therapeutics, Inc. Ultrasoft embolism devices and process for using them
US5423849A (en) * 1993-01-15 1995-06-13 Target Therapeutics, Inc. Vasoocclusion device containing radiopaque fibers
US5523092A (en) * 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US5409015A (en) * 1993-05-11 1995-04-25 Target Therapeutics, Inc. Deformable tip super elastic guidewire
US5514115A (en) * 1993-07-07 1996-05-07 Device For Vascular Intervention, Inc. Flexible housing for intracorporeal use
US5618301A (en) * 1993-10-07 1997-04-08 Angiomed Ag Reducing stent, device with reducing stent and use of a reducing stent
US5632772A (en) * 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5624449A (en) * 1993-11-03 1997-04-29 Target Therapeutics Electrolytically severable joint for endovascular embolic devices
US5423829A (en) * 1993-11-03 1995-06-13 Target Therapeutics, Inc. Electrolytically severable joint for endovascular embolic devices
US5520194A (en) * 1993-12-07 1996-05-28 Asahi Intecc Co., Ltd. Guide wire for medical purpose and manufacturing process of coil thereof
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5417708A (en) * 1994-03-09 1995-05-23 Cook Incorporated Intravascular treatment system and percutaneous release mechanism therefor
US5876432A (en) * 1994-04-01 1999-03-02 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
US5725572A (en) * 1994-04-25 1998-03-10 Advanced Cardiovascular Systems, Inc. Radiopaque stent
US5522819A (en) * 1994-05-12 1996-06-04 Target Therapeutics, Inc. Dual coil medical retrieval device
US5720764A (en) * 1994-06-11 1998-02-24 Naderlinger; Eduard Vena cava thrombus filter
US5522836A (en) * 1994-06-27 1996-06-04 Target Therapeutics, Inc. Electrolytically severable coil assembly with movable detachment point
US5637113A (en) * 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
US5514176A (en) * 1995-01-20 1996-05-07 Vance Products Inc. Pull apart coil stent
US5601593A (en) * 1995-03-06 1997-02-11 Willy Rusch Ag Stent for placement in a body tube
US5766219A (en) * 1995-04-20 1998-06-16 Musc Foundation For Research Development Anatomically shaped vasoocclusive device and method for deploying same
US5639277A (en) * 1995-04-28 1997-06-17 Target Therapeutics, Inc. Embolic coils with offset helical and twisted helical shapes
US5749891A (en) * 1995-06-06 1998-05-12 Target Therapeutics, Inc. Multiple layered vaso-occlusive coils
US5624461A (en) * 1995-06-06 1997-04-29 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
US6013084A (en) * 1995-06-30 2000-01-11 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US5603694A (en) * 1995-10-17 1997-02-18 Brown; Joe E. Infusion coil apparatus and method for delivering fluid-based agents intravascularly
US5709707A (en) * 1995-10-30 1998-01-20 Children's Medical Center Corporation Self-centering umbrella-type septal closure device
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US5733326A (en) * 1996-05-28 1998-03-31 Cordis Corporation Composite material endoprosthesis
US5762615A (en) * 1996-06-04 1998-06-09 Cordis Corporation Guideware having a distal tip with variable flexibility
US6168592B1 (en) * 1996-07-26 2001-01-02 Target Therapeutics, Inc. Aneurysm closure device assembly
US5733329A (en) * 1996-12-30 1998-03-31 Target Therapeutics, Inc. Vaso-occlusive coil with conical end
US5741327A (en) * 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
US6340367B1 (en) * 1997-08-01 2002-01-22 Boston Scientific Scimed, Inc. Radiopaque markers and methods of using the same
US6171326B1 (en) * 1998-08-27 2001-01-09 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
copy of www.merriam-webster.com/dictionary/twist; copied 5/27/2014 *

Cited By (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326225B2 (en) * 1997-12-05 2008-02-05 Micrus Endovascular Corporation Vasoocclusive device for treatment of aneurysms
US20040243168A1 (en) * 1997-12-05 2004-12-02 Ferrera David A. Vasoocclusive device for treatment of aneurysms
WO2009002412A2 (en) * 2007-06-22 2008-12-31 Neurovasx, Inc. Aneurysm filler detacher
WO2009002412A3 (en) * 2007-06-22 2009-03-05 Neurovasx Inc Aneurysm filler detacher
US20090082800A1 (en) * 2007-09-21 2009-03-26 Insera Therapeutics Llc Distal Embolic Protection Devices With A Variable Thickness Microguidewire And Methods For Their Use
US9034007B2 (en) 2007-09-21 2015-05-19 Insera Therapeutics, Inc. Distal embolic protection devices with a variable thickness microguidewire and methods for their use
US8366738B2 (en) 2007-11-09 2013-02-05 Micrus Endovascular Corporation Tethered coil for treatment of body lumens
US8906058B2 (en) 2007-11-09 2014-12-09 DePuy Synthes Products, LLC Tethered coil for treatment of body lumens
US8728115B2 (en) 2007-11-09 2014-05-20 DePuy Synthes Products, LLC Tethered coil for treatment of body lumens
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US8715227B2 (en) * 2008-07-22 2014-05-06 Cook Medical Technologies Llc Multi-stranded apparatus for treating a medical condition
US10271868B2 (en) 2008-07-22 2019-04-30 Cook Medical Technologies Llc Multi-stranded apparatus for treating a medical condition
US20100023035A1 (en) * 2008-07-22 2010-01-28 Cook Incorporated Multi-stranded apparatus for treating a medical condition
US9808252B2 (en) 2009-04-02 2017-11-07 Endoshape, Inc. Vascular occlusion devices
US9936892B1 (en) * 2009-05-04 2018-04-10 Cortex Manufacturing Inc. Systems and methods for providing a fiducial marker
US10952632B2 (en) 2009-05-04 2021-03-23 Cortex Manufacturing Inc. Imaging fiducial markers and methods
US8100881B2 (en) 2009-08-04 2012-01-24 Cook Medical Technologies Llc Flexible medical device for clot removal from small vessels
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
AU2010339980B2 (en) * 2009-12-16 2014-04-24 Endoshape, Inc. Multi-fiber shape memory device
WO2011084536A3 (en) * 2009-12-16 2011-11-03 Endoshape, Inc. Multi-fiber shape memory device
AU2010339980C1 (en) * 2009-12-16 2014-07-10 Endoshape, Inc. Multi-fiber shape memory device
US20120158034A1 (en) * 2010-12-16 2012-06-21 Wilson Thomas S Expandable Implant and Implant System
US10898199B2 (en) 2010-12-16 2021-01-26 Lawrence Livermore National Security, Llc Expandable implant and implant system
US11771435B2 (en) 2010-12-16 2023-10-03 Lawrence Livermore National Security, Llc Expandable implant and implant system
US10010327B2 (en) * 2010-12-16 2018-07-03 Lawrence Livermore National Security, Llc Expandable implant and implant system
US10201351B2 (en) 2011-09-30 2019-02-12 Endoshape, Inc. Continuous embolic coil and methods and devices for delivery of the same
US10603043B2 (en) 2012-01-17 2020-03-31 Endoshape, Inc. Occlusion device for a vascular or biological lumen
WO2013130937A1 (en) * 2012-03-01 2013-09-06 Tufts University Endovascular silk-protein based embolization of blood vessels
US10342655B2 (en) 2013-03-15 2019-07-09 Insera Therapeutics, Inc. Methods of treating a thrombus in an artery using cyclical aspiration patterns
US8852227B1 (en) 2013-03-15 2014-10-07 Insera Therapeutics, Inc. Woven radiopaque patterns
US10251739B2 (en) 2013-03-15 2019-04-09 Insera Therapeutics, Inc. Thrombus aspiration using an operator-selectable suction pattern
US10335260B2 (en) 2013-03-15 2019-07-02 Insera Therapeutics, Inc. Methods of treating a thrombus in a vein using cyclical aspiration patterns
US9901435B2 (en) 2013-03-15 2018-02-27 Insera Therapeutics, Inc. Longitudinally variable vascular treatment devices
US9833251B2 (en) 2013-03-15 2017-12-05 Insera Therapeutics, Inc. Variably bulbous vascular treatment devices
US10463468B2 (en) 2013-03-15 2019-11-05 Insera Therapeutics, Inc. Thrombus aspiration with different intensity levels
US9750524B2 (en) 2013-03-15 2017-09-05 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy systems
US8882797B2 (en) 2013-03-15 2014-11-11 Insera Therapeutics, Inc. Methods of embolic filtering
US8895891B2 (en) 2013-03-15 2014-11-25 Insera Therapeutics, Inc. Methods of cutting tubular devices
US8904914B2 (en) 2013-03-15 2014-12-09 Insera Therapeutics, Inc. Methods of using non-cylindrical mandrels
US8783151B1 (en) 2013-03-15 2014-07-22 Insera Therapeutics, Inc. Methods of manufacturing vascular treatment devices
US8910555B2 (en) 2013-03-15 2014-12-16 Insera Therapeutics, Inc. Non-cylindrical mandrels
US8753371B1 (en) 2013-03-15 2014-06-17 Insera Therapeutics, Inc. Woven vascular treatment systems
US9592068B2 (en) 2013-03-15 2017-03-14 Insera Therapeutics, Inc. Free end vascular treatment systems
US11298144B2 (en) 2013-03-15 2022-04-12 Insera Therapeutics, Inc. Thrombus aspiration facilitation systems
US9179931B2 (en) 2013-03-15 2015-11-10 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy systems
US9179995B2 (en) 2013-03-15 2015-11-10 Insera Therapeutics, Inc. Methods of manufacturing slotted vascular treatment devices
US9314324B2 (en) 2013-03-15 2016-04-19 Insera Therapeutics, Inc. Vascular treatment devices and methods
US8932320B1 (en) 2013-07-29 2015-01-13 Insera Therapeutics, Inc. Methods of aspirating thrombi
US10751159B2 (en) 2013-07-29 2020-08-25 Insera Therapeutics, Inc. Systems for aspirating thrombus during neurosurgical procedures
US8872068B1 (en) 2013-07-29 2014-10-28 Insera Therapeutics, Inc. Devices for modifying hypotubes
US8870901B1 (en) 2013-07-29 2014-10-28 Insera Therapeutics, Inc. Two-way shape memory vascular treatment systems
US8869670B1 (en) 2013-07-29 2014-10-28 Insera Therapeutics, Inc. Methods of manufacturing variable porosity devices
US8870910B1 (en) 2013-07-29 2014-10-28 Insera Therapeutics, Inc. Methods of decoupling joints
US8866049B1 (en) 2013-07-29 2014-10-21 Insera Therapeutics, Inc. Methods of selectively heat treating tubular devices
US8863631B1 (en) * 2013-07-29 2014-10-21 Insera Therapeutics, Inc. Methods of manufacturing flow diverting devices
US8859934B1 (en) 2013-07-29 2014-10-14 Insera Therapeutics, Inc. Methods for slag removal
US8845679B1 (en) 2013-07-29 2014-09-30 Insera Therapeutics, Inc. Variable porosity flow diverting devices
US8845678B1 (en) 2013-07-29 2014-09-30 Insera Therapeutics Inc. Two-way shape memory vascular treatment methods
US8828045B1 (en) 2013-07-29 2014-09-09 Insera Therapeutics, Inc. Balloon catheters
US8816247B1 (en) 2013-07-29 2014-08-26 Insera Therapeutics, Inc. Methods for modifying hypotubes
US8813625B1 (en) 2013-07-29 2014-08-26 Insera Therapeutics, Inc. Methods of manufacturing variable porosity flow diverting devices
US10390926B2 (en) 2013-07-29 2019-08-27 Insera Therapeutics, Inc. Aspiration devices and methods
US8803030B1 (en) 2013-07-29 2014-08-12 Insera Therapeutics, Inc. Devices for slag removal
US8728116B1 (en) 2013-07-29 2014-05-20 Insera Therapeutics, Inc. Slotted catheters
US8795330B1 (en) 2013-07-29 2014-08-05 Insera Therapeutics, Inc. Fistula flow disruptors
US8790365B1 (en) 2013-07-29 2014-07-29 Insera Therapeutics, Inc. Fistula flow disruptor methods
US8932321B1 (en) 2013-07-29 2015-01-13 Insera Therapeutics, Inc. Aspiration systems
US8728117B1 (en) 2013-07-29 2014-05-20 Insera Therapeutics, Inc. Flow disrupting devices
US8784446B1 (en) 2013-07-29 2014-07-22 Insera Therapeutics, Inc. Circumferentially offset variable porosity devices
US8735777B1 (en) 2013-07-29 2014-05-27 Insera Therapeutics, Inc. Heat treatment systems
US11627950B2 (en) 2015-01-20 2023-04-18 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
US11006940B2 (en) 2015-01-20 2021-05-18 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
US11096679B2 (en) 2015-01-20 2021-08-24 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
US11786255B2 (en) 2015-01-20 2023-10-17 Neurogami Medical, Inc Packaging for surgical implant
US11241223B2 (en) 2015-01-20 2022-02-08 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
US10857012B2 (en) 2015-01-20 2020-12-08 Neurogami Medical, Inc. Vascular implant
US10925611B2 (en) 2015-01-20 2021-02-23 Neurogami Medical, Inc. Packaging for surgical implant
US11484319B2 (en) 2015-01-20 2022-11-01 Neurogami Medical, Inc. Delivery system for micrograft for treating intracranial aneurysms
US11779452B2 (en) 2015-01-20 2023-10-10 Neurogami Medical, Inc. Vascular implant
US11369720B2 (en) 2015-07-27 2022-06-28 The Texas A&M University System Medical devices coated with shape memory polymer foams
US10561765B2 (en) 2015-07-27 2020-02-18 The Texas A&M University System Medical devices coated with shape memory polymer foams
US11219520B2 (en) 2017-03-14 2022-01-11 Shape Memory Medical, Inc. Shape memory polymer foams to seal space around valves
US11504131B2 (en) 2017-07-31 2022-11-22 Kaneka Corporation In-vivo indwelling instrument, in-vivo indwelling instrument delivering system and method for producing in-vivo indwelling instrument
US20230321325A1 (en) * 2018-03-12 2023-10-12 Fluid Biomed Inc. Bioabsorbable flow diverting scaffold and methods for its use

Also Published As

Publication number Publication date
EP1035808B1 (en) 2004-03-10
DE69822331T2 (en) 2004-08-05
WO1999029260A2 (en) 1999-06-17
DE69822331D1 (en) 2004-04-15
EP1219246B1 (en) 2006-03-08
WO1999029260A3 (en) 1999-09-02
US7326225B2 (en) 2008-02-05
EP1669032A3 (en) 2006-06-21
DE69833699D1 (en) 2006-05-04
JP2001525217A (en) 2001-12-11
JP4303419B2 (en) 2009-07-29
JP4528826B2 (en) 2010-08-25
DE69833699T2 (en) 2006-08-17
AU1711799A (en) 1999-06-28
US6159165A (en) 2000-12-12
US20040243168A1 (en) 2004-12-02
US6616617B1 (en) 2003-09-09
EP1219246A3 (en) 2003-08-13
EP1669032A2 (en) 2006-06-14
EP1035808A2 (en) 2000-09-20
JP2008119488A (en) 2008-05-29
EP1219246A2 (en) 2002-07-03

Similar Documents

Publication Publication Date Title
US6616617B1 (en) Vasoocclusive device for treatment of aneurysms
US6475169B2 (en) Micro-strand cable with enhanced radiopacity
US6241691B1 (en) Coated superelastic stent
US7070608B2 (en) Vasoocclusive coil
US6171326B1 (en) Three dimensional, low friction vasoocclusive coil, and method of manufacture
US7316701B2 (en) Three dimensional, low friction vasoocclusive coil, and method of manufacture
US8790363B2 (en) Three dimensional, low friction vasoocclusive coil, and method of manufacture

Legal Events

Date Code Title Description
AS Assignment

Owner name: DEPUY SYNTHES PRODUCTS, LLC, MASSACHUSETTS

Free format text: CHANGE OF NAME;ASSIGNOR:HAND INNOVATIONS LLC;REEL/FRAME:030353/0083

Effective date: 20121231

Owner name: CODMAN & SHURTLEFF, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MICRUS ENOVASCULAR LLC;REEL/FRAME:030352/0972

Effective date: 20121230

Owner name: HAND INNOVATIONS LLC, FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DEPUY SPINE, LLC;REEL/FRAME:030353/0075

Effective date: 20121230

Owner name: DEPUY SPINE, LLC, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CODMAN & SHURTLEFF, INC.;REEL/FRAME:030352/0987

Effective date: 20121230

AS Assignment

Owner name: CODMAN & SHURTLEFF, INC., MASSACHUSETTS

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVE SERIAL NUMBER 12/554,588 PREVIOUSLY RECORDED ON REEL 030352 FRAME 0973. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:MICRUS ENDOVASCULAR LLC;REEL/FRAME:034535/0733

Effective date: 20121230

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION